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Abstract 
 
 
The Psychometric Properties of Older Adult Self-Report Anxiety Measures: 
A Systematic Review 
Appropriate anxiety assessment for older adults is based on validated 
measurement.  Without sound psychometric tools, accuracy of assessment is 
compromised.  This review considers the practicality of and psychometric evidence for 
self-report anxiety measures designed specifically for use with older adults.  Reviewing 
17 articles, a total of 8 older adult anxiety measures met inclusion criteria, with the 
Geriatric Anxiety Inventory (Pachana, Byrne, Siddle, Koloski, Harley & Arnold, 2007) 
having the most evidence of sound psychometric foundations.  Most of the older adult 
specific anxiety measures were found to be accessible for clinical use and have low 
practical burden.    Methodological critique of the studies is discussed, as well as 
directions for future research.      
 
 The Clinical Effectiveness of Group Psychoeducational Cognitive 
Behavioural Therapy for Mixed Anxiety and Depression in Older Adults: A 
Feasibility Study 
There is a dearth of literature in relation to group interventions that address co-
morbid anxiety and depression for older adults. This research evaluates the clinical 
effectiveness of a manualised 6 session cognitive behavioural psychoeducational group 
programme for older adults using a pre-post and short term follow up design.   
Patients (N=34) meeting specified inclusion criteria attended a group (N=8).  A battery 
of process and outcome measures, Hospital Anxiety and Depression Scale (Zigmond & 
Snaith, 1983), Clinical Outcomes in Routine Evaluation – Outcome Measure (Barkham 
et al., 1998) and Health of the Nation Outcome Scale 65+ (Burns et al., 1999) were 
completed at assessment, termination and 6 week follow up.  All outcome measures 
v 
 
demonstrated improvement from assessment to termination and assessment to follow up 
comparisons.  On the CORE-OM, 28% of patients reliably improved and 22% were 
classified as recovered at termination.   
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Abstract 
 
Purpose.  Appropriate assessment of anxiety for older adults is based on validated 
measurement.  Without sound psychometric tools, accuracy of assessment is 
compromised.  This review considers the practicality for and psychometric evidence for 
self-report anxiety measures designed specifically for use with older adults.   
Method.  Studies were extracted from PsycARTICLES, PsycINFO and PubMed using 
Ovid and ISI Web of Knowledge search tools.  Databases were searched up until the 
20
th
 of May 2012.  A total of 17 articles were reviewed. 
Results.   A total of 8 older adult anxiety measures met inclusion criteria, with the 
Geriatric Anxiety Inventory (Pachana, Byrne, Siddle, Koloski, Harley & Arnold, 2007) 
having the most evidence of sound psychometric foundations.  All 8 measures had low 
practical burden, however several lacked robust investigation of their psychometric 
properties. 
Conclusions.   The current review systematically considered validation studies of older 
adult specific anxiety measures.  The Geriatric Anxiety Inventory (Pachana, Byrne, 
Siddle, Koloski, Harley & Arnold, 2007) demonstrated most evidence of reliability and 
validity.  Most of the older adult specific anxiety measures were found to be accessible 
for clinical use and have low practical burden.    Methodological critique of the studies 
is discussed, as well as directions for future research.      
 
Keywords: older adults; anxiety; assessment; self-report; psychometric; systematic 
review 
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Anxiety disorders are highly prevalent in older adults (OAs) across cultures 
(Bryant, Jackson, & Ames, 2008).  The estimated projected risk of any anxiety disorder 
at the age of 75 varies from 6% in China to 36% in the USA (Kessler et al., 2007).  
Despite high prevalence, anxiety is still under-diagnosed and treated (Byrne & Pachana, 
2011).  Dennis, Boddington, & Funnell (2007) noted that OA anxiety research has not 
developed at the same rate as research with working age adults.   
Anxiety disorders are more prevalent in OAs with chronic medical conditions 
and are highly co-morbid with depressive disorders (Beekman et al., 2000; Lenze et al., 
2001).  Mohlman (2004) stated that OAs with Generalised Anxiety Disorder (GAD) are 
at a significantly higher risk of a co-morbid depressive disorder and co-morbidity 
increases the risk of suicide (Lenze et al., 2001).  Excessive worry is considered to be 
one of the main characteristics of GAD and features in most anxiety disorders (Brown, 
Antony & Barlow, 1992).  Worry has been found to be a prevalent facet of anxiety for 
OAs, particularly in relation to health, family, and keeping independence (Wisocki, 
1994).  The assessment challenges faced in this field include symptoms of anxiety being 
confused with aspects of normal aging (Lenze & Wetherell, 2009), the high co-
morbidity rate of anxiety and depression in OAs (Beekman et al., 2000) and the overlap 
of the somatic symptoms of medical conditions with anxiety (Kogan, Edelstein & 
McKee, 2000).   
  Self-report is an efficient aspect of anxiety assessment and is particularly 
appropriate to measure subjective states (James, Reynolds & Dunbar, 1994).  Sound 
anxiety assessment for OAs is based on use of standardised measures and without 
psychometrically validated tools, clinical effectiveness is compromised (Hersen & Van 
Hasselt, 1992).  The importance of psychometrically sophisticated measures of anxiety 
is therefore a clinical imperative (Portman, Starcevic & Beck, 2011).   
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The most commonly used measures of anxiety in OAs have recently undergone 
a systematic review (Therrien & Hunsley, 2012) which highlighted that the most 
commonly used measures with this population are designed, in fact, for younger people.  
Although some mention of OA specific measures is made, no attempt was made to 
review the psychometric properties of OA specific anxiety measures.  The central aim 
of this paper is therefore to review the psychometric foundations of self-report anxiety 
measures (including worry), designed specifically for use with OAs.  In addition to this, 
the practical use of these measures is discussed, including practical burden and financial 
implications.  The term ‘OAs’ generally applies to those aged over 65, however, any 
literature suggestive of using an older population will be considered.    
 
Method 
Literature Search 
Studies used in this review were extracted from PsycARTICLES, PsycINFO and 
PubMed using Ovid and ISI Web of Knowledge search tools.  In addition to this, 
reference sections of articles were searched as well as citation searches for any relevant 
literature.  Databases were searched up until the 20
th
 of May 2012 and articles from any 
publication date were used.  The following keywords were searched in various 
combinations: ‘anxi*’, ‘outcome measure’, ‘assessment’ ‘elder*’, ‘psychometric’, 
‘old*’, ‘late life’, ‘geriatric’, ‘aging’, ‘gerontology’, ‘validity’ ‘reliability’.  Inclusion of 
articles was based on the title and abstract, full texts of articles were read if necessary.  
Only English publications were included.  Filters were used to exclude dementia 
samples, child samples and research with animals.  Literature was excluded if the 
primary focus was not considering the psychometric properties of anxiety/worry 
measures designed specifically for use with OAs.  Figure 1 details part 1 of the 
literature search process.   
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Figure 1.  Flow Chart of the Literature Search Process Part 1 
 
From this search strategy, the following anxiety measures were identified, Adult 
Manifest Anxiety Scale – Elderly (AMAS-E; Reynolds, Richmond & Lowe (2003) 
cited in Lowe & Reynolds, 2006), Geriatric Anxiety Inventory (GAI; Pachana, Byrne, 
Siddle, Koloski, Harley & Arnold, 2007), Geriatric Anxiety Inventory – Short Form 
(GAI-SF; Byrne & Pachana, 2011), Geriatric Anxiety Scale (GAS; Segal, June, Payne, 
Coolidge & Yochim, 2010), Geriatric Worry Scale (GWS; Diefenbach, Tolin, Meunier 
& Gilliam, 2009), Short Anxiety Screening Test (SAST; Sinoff, Ore, Zlotogorsky & 
Tamir, 1999), Worry Scale (WS; Wisocki & Handen (1983) cited in Wisocki, Handen 
& Morse, 1986), and the Worry Scale for Older Adults – Revised (WSOA-R; Wisocki, 
1994). 
 ‘anxi*’, ‘outcome measure’, ‘assessment’ ‘elder*’, ‘psychometric’, ‘old*’, ‘late life’, 
‘geriatric’, ‘aging’, ‘gerontology’, ‘validity’ ‘reliability’ 
Web of 
Knowledge: 88 
PsycINFO & 
PsycARTICLES: 855 
PubMed: 
710 
Within 
Reference 
Sections: 
14 
Included in 
the final 
review: 
9 
Excluded: 
1658 
Reason for exclusion: 
 Measure of depression 
only 
 Dementia 
 Not OA specific 
 Duplicates 
 Primary measure not 
anxiety e.g. quality of 
life, optimism, ADL 
 Research focus on 
specific sample e.g. 
rehabilitation, cancer, 
multiple sclerosis 
 Carers  
 Not self-report 
 Not in English 
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Measures considering specific phobias or specific anxiety disorders (e.g. panic, 
agoraphobia, social) were excluded, to focus exclusively on anxiety.  Further searches 
were conducted using the names of each of these measures; search results are detailed 
below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Flow Chart of the Literature Search Process Part 2 
 
Definition of the Psychometric Properties Included  
Psychometric properties relate to reliability and validity.  Reliability is the 
consistency and reproducibility of a measure, and validity “whether or not a measure 
actually measures what it is intended to measure” (McGoey, Cowan, Rumrill & 
LaVogue, 2010, p. 109).  Considered collectively, reliability and validity establish the 
PsycINFO & 
PsycARTICLES:  
483 
Name of Measure  
Web of 
Knowledge:  
36 
Within 
Reference 
Sections: 
6 
Excluded: 
517 
Included in 
the final 
review: 
8 
Reason for exclusion: 
 Not considering 
psychometric properties 
 Cognitive impairment 
 Already obtained in last 
search strategy 
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parameters of psychometric properties. Tables 1 and 2 summarise the areas of reliability 
and validity that are considered within this review.    
 
Table 1.  
Measures of Reliability 
Criterion   Definition 
   Internal 
Consistency 
 
Stability of scores across items that comprise the assessment e.g. 
measuring whether the items of a scale are measuring the same thing 
(indicating high consistency).  An assessment is considered 
internally consistent when items are highly correlated with one 
another.  This is usually measured by Cronbach's alpha.  The 
following descriptions are used within this review based on 
descriptions cited in George & Mallery., (2003): a = > 0.9 
(excellent); 0.9 > a = > 0.8 (good); 0.8 > a = > 0.7 (acceptable); 0.7 
> a > 0.6 (questionable); 0.6 > a > 0.5 (poor); 0.5 > a (unacceptable) 
 
 
 
Test-retest 
 
Measure of stability or consistency of an assessment across separate 
administrations of the same assessment. 
 
 
 
Inter-rater 
  
Measure of two or more assessment scorers or observers.  Measured 
by considering the correlation between the raters.  This is usually 
not applicable with self-report measures, however, may be reported 
if the measure was rated by an interviewer/researcher.   
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Table 2.  
Measures of Validity 
 
Criterion    Definition 
   
Construct  Extent to which an assessment accurately measures a construct or 
trait i.e. the degree to which operationalisations of a construct 
actually measure what the theory states it does.  Construct validity is 
more than a single statistic but rather a process of information 
gathering to build evidence.   
   
Convergent  Extent to which an assessment is similar to (converges on) other 
operationalisations that it theoretically should be similar to.  High 
correlations are evidence of greater convergent validity. 
   
Discriminant  Extent to which the assessment is not similar to (discriminates from) 
other assessments that it theoretically should not be similar to. 
   
Sensitivity  Measure of the proportion of actual positives that are correctly 
identified e.g. percentage of people identified as having a condition 
that they do actually have. 
   
Specificity   Proportion of negatives which are correctly identified e.g. percentage 
of people identified as not having a condition that they do not have. 
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Quality Assessment 
There is no established tool to consider the quality of studies of psychometric 
properties of measures.  Therefore, a bespoke tool was devised (Appendix A) that 
combined seven relevant items from the Downs and Black checklist (Downs & Black, 
1998) and five areas detailed by Bot et al., (2003) that consider self-report measures.  
Items included were agreed between authors.   
The Downs and Black checklist (1998) considers the relative strength of a 
study’s design and has been used widely, has internal consistency, content and criterion 
validity (National Collaborating Centre for Methods and Tools, 2008).  Results from the 
items in this checklist can be seen in Table 3.  Bot et al., (2003) highlight the following 
areas as vital when considering psychometric properties of self-report measures; 
validity, reproducibility (reliability), responsiveness, interpretability and practical 
burden.  This checklist has been utilised in other systematic reviews (Castelino, Abbott, 
McElhone, Teh, Lee-Suan, 2009).    All of these areas were therefore considered when 
assessing the psychometric properties of OA anxiety measures (results can be seen in 
Tables 4 and 5).  All studies and measures were scored by the first author and (4/17) 
were chosen at random to be rated by a second author.  An intraclass correlation 
coefficient (ICC) was calculated to check for reliability.   
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Results 
 As detailed in Figures 1 and 2, the search process highlighted 17 studies which 
considered 8 anxiety measures; summaries of these studies can be seen in Table 3.  
Study quality varied from 3-5 for the Downs and Black (1998) checklist.  Tables 4 and 
5 give an overview of the practical implications and psychometric foundations of each 
measure, using the checklist devised by Bot et al., (2003).  Psychometric foundations of 
the anxiety measures are considered in further detail through the discussion.  Good 
levels of agreement were found between authors in terms of quality assessments 
(ICC=.708).  The Downs and Black (1998) checklist was not particularly helpful to 
comment on study quality on this occasion, as all studies scored similarly and there was 
no cut-off criteria available.  The criteria set by Bot et al., (2003) provided a helpful 
framework to consider reliability, validity and the practical use of the measures as 
highlighted in Tables 4 and 5.    
Overview of Measures 
Adult Manifest Anxiety Scale – Elderly (AMAS-E; Reynolds, Richmond & 
Lowe (2003) cited in Lowe & Reynolds, 2006).  The AMAS-E assesses chronic, 
manifest anxiety and is derived from Taylor’s Manifest Anxiety Scale (MAS; Taylor, 
1951).  The AMAS is available in three versions dependent on age group.  The measure 
contains 44 items with a yes/no response option.  Two studies were reviewed in relation 
to the AMAS-E (Table 3).   
Geriatric Anxiety Inventory (GAI; Pachana, Byrne, Siddle, Koloski, Harley 
& Arnold, 2007).  The GAI was designed to address some of the weaknesses in the 
field of OA specific anxiety measures.  The 20 item measure has an agree/disagree 
response format.  The development of the GAI was designed to measure common 
symptoms of anxiety, rather than diagnose anxiety disorders.  The GAI items were 
developed using pre-existing measures of anxiety.  Sixty sample items were devised that 
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included different facets of anxiety (e.g. fear, worry, somatic symptoms etc).  These 60 
items were given to healthy OAs, and clinical psychologists and psychiatrists who 
commented on understanding, language and redundancy.  This reference group 
preferred the use of agree/disagree as response options.  These items were then piloted 
on a healthy community sample and an outpatient psychogeriatric sample and 20 items 
were chosen based on correlations.  Five studies were reviewed in relation to the GAI 
(Table 3).      
Geriatric Anxiety Inventory (GAI-SF; Byrne & Pachana, 2011).  Following 
on from the promising psychometric properties of the GAI, Byrne & Pachana (2011) 
developed a shorter 5 item version for use in geriatric medical settings.  The most 
endorsed items of the 20 item GAI from the research described in Byrne & Pachana 
(2011) were used in different combinations.  From this, 5 items were found to have the 
best ability to distinguish participants with GAD.  One study was reviewed in relation to 
the GAI-SF (Table 3).       
Geriatric Anxiety Scale (GAS; Segal, June, Payne, Coolidge & Yochim, 
2010).  The GAS is a 30 item measure with 4 point scale response options, varying from 
0 to 75.  The GAS was developed as a brief screening measure of anxiety specifically 
for an older population.  One of the most notable strengths of the development of the 
GAS is that the items for the measure were devised from the full range of anxiety 
disorder symptoms in the Diagnostic and Statistical Manual of Mental Disorders-4
th
 
Edition (DSM-IV; American Psychiatric Association, 2000).   The GAS was developed 
by comparing an older age group with a younger age group recruited from educational 
classes and student’s family members.  The items most highly rated by OAs were 
ranked.  This resulted in 25 items measuring a variety of anxiety symptoms.  In addition 
to this, 5 content items were included (not part of total score of GAS) to assess finances, 
children, health, fear of dying and fear of becoming a burden to family members.  This 
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additional information was included to provide some context to the individual and their 
anxiety (Segal et al., 2010).  Two studies were reviewed in relation to the GAS (Table 
3).   
Geriatric Worry Scale (GWS; Diefenbach, Tolin, Meunier & Gilliam, 
2009).  The GWS was constructed using the Geriatric Depression Scale (GDS; 
Yesavage et al., 1983) as a model.  Therefore, the GWS has a yes/no response choice 
and uses simple concrete language.  There are 5 items in total and positive items are 
scored with 1 point.  All items are scored in the same direction apart from the last 
question which is reverse scored.  One study was reviewed in relation to the GWS 
(Table 3).   
Short Anxiety Screening Test (SAST; Sinoff, Ore, Zlotogorsky & Tamir, 
1999).  The SAST was developed to screen specifically for anxiety in the elderly 
depressed.  The measure includes modified items from other anxiety measures.  Sinoff 
et al (1999) explain that somatic symptom items were deliberately included due to their 
relevance with OA populations.  A cut-off of  > 24 was suggested based on pilot 
research.  One study was reviewed in relation to the SAST (Table 3).    
Worry Scale (WS; Wisocki & Handen, 1983 cited in Wisocki, Handen & 
Morse, 1986).  The Worry Scale (WS) was devised specifically to consider ‘negative 
cognitive activity’ in OAs (Wisocki, Handen & Morse, 1986).  The development 
rationale was (a) due to OAs in previous research finding common anxiety measures 
difficult to complete/irrelevant, (b) the need for a direct measure of respondents’ 
perception of stress and (c) to review areas that are worrying for this client group.  The 
WS considers finances, health and social conditions and the questions are designed to 
relate to the experience of OAs.  The details of the way in which items were developed 
are not available, as the reference for the WS is unpublished.  The WS has 35 items and 
respondents are asked to rate on a 5 point scale how relevant statements are.  The WS 
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also provides additional space for respondents to comment on any worries that are not 
covered in the measure.  Four studies were reviewed in relation to the WS (Table 3).       
Worry Scale for OAs-Revised (WSOA-R; Wisocki., 1994).  The WSOA-R is 
a revised version of the original WS.  Additional items were included and the WSOA-R 
is comprised of 88 items in 6 domains; finances, health, social conditions, personal 
concerns, family concerns and world issues.  These items were collected by a series of 
focus groups of OAs, who classified themselves as chronic worriers.  Ratings are made 
on a 5 point scale.  The measure also includes a separate 16 item coping inventory 
which considers coping strategies used to manage worry (e.g. ‘I reason with myself’ or 
‘I laugh about it’).  One study was reviewed in relation to the WSOA-R (Table 3).    
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Table 3.  
 
Summary of Older Adult Anxiety Measure Studies  
 
    Study Details   Participants 
  
Quality 
Rating  
Measure  Author 
(year) 
Aim Findings  N            
(% female) 
Mean age 
(range) 
Recruitment 
(country) 
  
Downs & 
Black 
Checklist 
(Partial) 
AMAS - 
E  
 Lowe & 
Reynolds 
(2006) 
a) Examine the reliability 
and validity of the AMAS-
E. 
Adequate to excellent 
internal consistency 
and temporal stability.  
Support for convergent, 
and discriminant 
validity. 
 226       
(51) 
76.85         
(60 and 
older) 
community 
(USA) 
 
4 
   b) Structure of the AMAS-
E was examined across 
gender. 
Structure of the 
AMAS-E scale and 
subscales similar 
across gender. 
 863       
(64) 
76.25        
(60-100) 
community 
(USA) 
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    Study Details   Participants 
  
Quality 
Rating  
Measure  Author 
(year) 
Aim Findings  N            
(% female) 
Mean age 
(range) 
Recruitment 
(country) 
  
Downs & 
Black 
Checklist 
(Partial) 
AMAS-
E 
 Lowe & 
Reynolds 
(2000)  
Investigate whether the 
three factor structure of 
anxiety that they had 
found to be appropriate 
with children was 
appropriate with older 
adults. 
Some similarities of 
anxiety across the life 
span. Excellent internal 
consistency. 
 458       
(80) 
78.52       
(60-100) 
community 
(USA) 
 
5 
         
 
 
GAI  Byrne et al., 
(2010) 
Consider the psychometric 
properties of the GAI with 
older Australian women. 
High levels of 
sensitivity and 
specificity, evidence of 
convergent validity. 
 286      
(100) 
71.7         
(60-86) 
community 
(Australia) 
 
4 
         
 
 
GAI  Cheung 
(2007) 
Consider the validity of 
the GAI in late-life 
depression. 
Convergent validity for 
the GAI with a 
depressed sample. 
 32        
(62.5) 
75.5         
(66-85) 
clinical 
community 
mental health 
services (New 
Zealand) 
 
3 
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    Study Details   Participants 
  
Quality 
Rating  
Measure  Author 
(year) 
Aim Findings  N            
(% female) 
Mean age 
(range) 
Recruitment 
(country) 
  
Downs & 
Black 
Checklist 
(Partial) 
         
 
 
GAI  Cheung et 
al., (2012) 
Consider the sensitivity 
and specificity of the GAI 
and HADS in detecting 
anxiety disorders in older 
adults with chronic 
obstructive pulmonary 
disease. 
High levels of 
sensitivity and 
specificity for both the 
GAI and HADS when 
lower cut off points are 
applied. 
 55         
(44.4) 
72.7          
(not stated) 
clinical 
respiratory 
service (New 
Zealand) 
 
5 
         
 
 
GAI  Matheson et 
al., (2012) 
Consider the validity and 
reliability of the GAI in 
Parkinson's Disease. 
Excellent internal 
consistency, high levels 
of sensitivity and 
specificity. 
 58          
(43) 
66.24             
(37-85) 
outpatients 
clinics 
(Australia) 
 
4 
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    Study Details   Participants 
  
Quality 
Rating  
Measure  Author 
(year) 
Aim Findings  N            
(% female) 
Mean age 
(range) 
Recruitment 
(country) 
  
Downs & 
Black 
Checklist 
(Partial) 
GAI  Pachana et 
al., (2007) 
a) Development and 
validation of the GAI in a 
community sample. 
Excellent internal 
consistency and 
convergent validity. 
 313 (66.7)                     
189 (63.5) 
69.5 (42-90)                    
71.4 (60-88) 
community 
(Australia) 
 
5 
   b) Development and 
validation of the GAI in a 
clinical sample. 
Excellent internal 
consistency, high levels 
of sensitivity and 
specificity. 
 46        
(74) 
78.8           
(66-94) 
clinical geriatric 
community 
psychiatric 
service 
(Australia) 
 
 
         
 
 
GAI - 
SF 
 Byrne & 
Pachana 
(2011) 
Development and 
validation of a short form 
of the GAI. 
Good internal 
consistency, high 
sensitivity and 
specificity. 
 284       
(100) 
72.2          
(60-87) 
community 
(Australia) 
 
5 
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    Study Details   Participants 
  
Quality 
Rating  
Measure  Author 
(year) 
Aim Findings  N            
(% female) 
Mean age 
(range) 
Recruitment 
(country) 
  
Downs & 
Black 
Checklist 
(Partial) 
GAS  Segal et al., 
(2010) 
a) Development and initial 
validation of the GAS. 
Good internal 
reliability in clinical 
and community 
samples.  Evidence of 
convergent validity. 
 100 
younger 
(83)          
 
30 older 
(70) 
24  
(17-49)                            
 
 
67  
(60-82) 
community 
(USA)
 
4 
        
 
 
        
 
 
   b) Development and initial 
validation of the GAS 
with other measures of 
anxiety and depression. 
 101       
(92) 
72             
(60-90) 
community 
(USA) 
 
 
        
 
 
        
 
 
   c) Development and initial 
validation of the GAS in a 
clinical population. 
 69        
(78) 
69             
(60-87) 
clinical 
outpatients 
(USA) 
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    Study Details   Participants 
  
Quality 
Rating  
Measure  Author 
(year) 
Aim Findings  N            
(% female) 
Mean age 
(range) 
Recruitment 
(country) 
  
Downs & 
Black 
Checklist 
(Partial) 
GAS  Yochim et 
al., (2011) 
Explore the convergent 
and discriminant validity 
of the GAS. 
Evidence of convergent 
validity, and 
discriminant validity 
with non-mental health 
problems. 
 117         
(62) 
74.75             
(60-89) 
community 
(USA) 
 
4 
         
 
 
GWS  Diefenbach 
et al.,           
(2009) 
Consider assessment 
measures for older home 
care recipients. 
Acceptable internal 
consistency, evidence 
of convergent validity. 
 66              
(83.3) 
76.46        
(65-92) 
community 
home care 
recipients 
(USA) 
 
5 
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    Study Details   Participants 
  
Quality 
Rating  
Measure  Author 
(year) 
Aim Findings  N            
(% female) 
Mean age 
(range) 
Recruitment 
(country) 
  
Downs & 
Black 
Checklist 
(Partial) 
SAST  Sinoff et al., 
(1999) 
Investigate the 
psychometric properties of 
the SAST, particularly 
with depressed 
individuals. 
Acceptable internal 
consistency, high levles 
of sensitivity and 
specificity, including in 
the presence of 
depression. 
 150  
(63.3) 
81.7  
(> 70) 
medical 
inpatients and 
outpatients 
(Israel) 
 
4 
         
 
 
WS  Hopko et al., 
(2000) 
Investigate the 
relationship between 
clinician severity ratings 
and patient self report 
measures. 
Evidence of convergent 
validity.  
 64        
(75) 
66.5         
(60-80) 
community 
GAD diagnosed 
(USA) 
 
5 
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    Study Details   Participants 
  
Quality 
Rating  
Measure  Author 
(year) 
Aim Findings  N            
(% female) 
Mean age 
(range) 
Recruitment 
(country) 
  
Downs & 
Black 
Checklist 
(Partial) 
WS  Stanley et 
al., (2001) 
Consider the psychometric 
properties of five anxiety 
measures in older adults. 
Excellent internal 
consistency, evidence 
of convergent validity, 
test retest reliability, 
poor discriminant 
validity with 
depression. 
 57  
(77.2) 
Not stated 
(60-80) 
community with 
GAD diagnosis 
(USA) 
 
4 
         
 
 
WS  Stanley, 
Beck & 
Zebb (1996) 
Consider the psychometric 
properties of four anxiety 
measures in older adults 
Excellent internal 
consistency for GAD 
sample, evidence of 
convergent validity  
 50 GAD 
(72)                 
 
94 Control 
(69.1)             
67.92  
(55-81)                    
 
67.53  
(55-82) 
community 
(USA) 
 
5 
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    Study Details   Participants 
  
Quality 
Rating  
Measure  Author 
(year) 
Aim Findings  N            
(% female) 
Mean age 
(range) 
Recruitment 
(country) 
  
Downs & 
Black 
Checklist 
(Partial) 
WS  Wisocki et 
al., (1986) 
Consider the WS in 
community and 
homebound samples. 
Some evidence of 
convergent validity for 
the WS. 
 
a) 54 (76)                       70
(not stated)                
community 
(USA) 
 
4 
     b) 44 (88) 77   
(not stated) 
community 
homebound 
(elderly) 
 
 
         
 
 
WSOA-
R 
  Hunt et al., 
(2003) 
Investigate worry and the 
use of coping strategies 
among older and younger 
adults. 
Excellent internal 
consistency for the 
WSOA-R.  Some 
evidence of convergent 
validity. 
  84 older 
(65.8)            
 
110 
younger 
(78.2)  
70.5  
(65-86)                     
 
20.7  
(18-25) 
community 
(USA) 
  
4 
 
Note.  AMAS-E=Adult Manifest Anxiety Scale-Elderly, GAD=Generalised Anxiety Disorder, GAI=Geriatric Anxiety Inventory, GAI-SF=Geriatric 
Anxiety Inventory-Short Form, GAS= Geriatric Anxiety Scale, GWS=Geriatric Worry Scale, HADS=Hospital Anxiety & Depression Scale, 
SAST=Short Anxiety Screening Test, WS=Worry Scale, WSOA-R=Worry Scale for Older Adults-Revised.
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Discussion 
Psychometric Foundations and Practical Utility 
Practical implications for the 8 measures are summarised in Table 4 and 
psychometric properties are displayed in Table 5.   
AMAS-E.  Lowe & Reynolds (2000) investigated if the three factor structure of 
anxiety found with children (worry/oversensitivity, physiological, and 
fear/concentration) was appropriate with OAs.  Four hundred and fifty eight participants 
were recruited from the community who did not have a DSM-IV diagnosis of anxiety 
(prior or current).  A three factor structure of anxiety for OAs was found with ‘fear of 
aging’ replacing ‘fear/concentration’.  Internal consistency was found to be excellent for 
the full scale and in the acceptable-excellent range for all subscales.   
The psychometric properties of the AMAS-E were further researched by Lowe 
and Reynolds (2006).  A community volunteer sample completed the 44 item AMAS-E 
and State Trait Anxiety Inventory (STAI; Spielberger, Gorssuch, Lushene, Vagg, & 
Jacobs, 1983).  Measures were repeated two weeks later.  The full AMAS-E 
demonstrated excellent internal consistency with the three subscales having adequate-
good internal consistency.  The AMAS-E has a reliable ‘lie’ scale of seven items, which 
serves as a validity index.     Convergent and discriminant validity was investigated 
using the STAI scores.  Validity coefficients were relatively higher for AMAS-E 
anxiety scores and STAI-Trait scale scores suggesting some evidence of convergent 
validity for the AMAS-E as a measure of manifest/trait anxiety.  There was also some 
evidence of discriminant validity as the AMAS-E correlated significantly higher with 
STAI-Trait than the STAI-State scale score.   
These studies highlight some support for the construct validity of the AMAS-E, 
particularly as it has undergone factor analysis and the subscales and total score 
significantly correlate with each other.  Evidence of test-retest reliability is also high; 
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however, research has yet to address sensitivity and specificity with this measure.  The 
AMAS-E is only available by purchase which can have practical implications for 
clinical use.   
GAI.  Pachana et al., (2007) investigated validation of the GAI initially using 
two community samples of healthy OAs.  Sixty items were condensed to 20 using 
correlations to consider the most useful items; the internal consistency of the 20 item 
version with community healthy OAs was excellent.  Convergent validity was 
demonstrated, as several anxiety measures significantly correlated with the GAI (Table 
5).   
The GAI was then considered with a clinical sample.  Convergent validity was 
measured and demonstrated strong positive correlations.  The GAI discriminated 
between participants with (or without) an anxiety disorder or GAD.  For detecting GAD 
the cut-off was found to be optimal at 10/11, and to identify participants with any 
anxiety disorder the cut-off was 8/9.   
Byrne et al., (2010) specifically considered the psychometric properties of the 
GAI in community residing women.  Two hundred and fifty three of the 286 women in 
the sample were also interviewed to assess for DSM-IV diagnoses and were 
administered the mini mental state examination (MMSE; Folstein, Folstein & McHugh, 
1975).  Results indicated that GAI score was associated with STAI-State scores, but not 
with age, MMSE score, self-reported life events or perceived social support suggesting 
that the GAI has discriminant validity with non-mental health problems.  The mean total 
was significantly different for those classified as having current GAD than those who 
were not.  The optimal cut-off for detecting current GAD was 8/9 and the GAI 
demonstrated high levels of sensitivity and specificity.  The research is comparable to 
that of Pachana et al., (2007) who used a mixed gender sample.   
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 The convergent validity of the GAI was investigated with a clinical population 
with a history of depression (Cheung, 2007).  Participants were from community mental 
health services.  This research highlighted that participants who were depressed also 
indicated greater anxiety symptoms and vice versa.  This supports the notion that 
anxiety and depressive symptoms are highly interrelated in this population (Lenze., 
2001).  Overall, the cut-off point of 8/9 identified participants with anxiety symptoms in 
late-life depression.  Convergent validity for the GAI was supported as significant 
relationships were found with other measures of anxiety, particularly the GAS.    
 Matheson et al., (2012) considered the psychometric properties of the GAI in 
patients with Parkinson’s disease (PD).  Fifty eight Neurology outpatients scoring >27 
on the MMSE with a diagnosis of idiopathic PD took part.  Results indicated no 
significant differences in relation to gender.  GAI scores were significantly higher in PD 
participants with an anxiety disorder suggesting that the GAI was measuring what it set 
out to measure.  The GAI indicated a satisfactory test-retest reliability and excellent 
internal consistency.  The optimum cut-off for anxiety with this clinical group was 6/7.  
This research highlights the GAI as a useful tool with PD patients; a population prone to 
anxiety disorders.  Despite the GAI’s deliberate exclusion of somatic items, it seems to 
capture the anxious symptoms of participants within a medically unhealthy sample, 
suggesting it may be useful in other health settings where samples are predominantly 
OAs.      
 Anxiety disorders are highly prevalent in people with chronic obstructive 
pulmonary disease (COPD), a condition that commonly affects OAs (Cheung et al., 
2012).  The GAI and Hospital Anxiety and Depression Scale (HADS; Zigmond & 
Snaith, 1983) have been recently used with this clinical group to consider sensitivity 
and specificity of detecting anxiety disorders (Cheung et al., 2012).  Fifty five volunteer 
participants completed the study, 14 of whom were identified as having an anxiety 
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and/or depressive disorder.  Participants with an identified anxiety disorder scored 
significantly higher on the GAI.  The optimum cut-off point for the GAI was 2/3. 
Psychiatric assessments were completed by an independent assessor who was blinded to 
the respiratory assessment results, suggesting assessment was not influenced by this 
information.  Diefenbach et al., (2009) also indicated some promising results for the 
GAI as a screening measure for anxiety.  This research is further discussed in relation to 
the Geriatric Worry Scale.   
The GAI has demonstrated construct validity based on significant correlations 
between items, evidence of convergent validity, high test-retest and inter-rater 
reliability, and consistently excellent internal consistency.  Research also highlights the 
importance of changing cut-off scores to reflect the client group.  Although discriminant 
validity has been demonstrated in relation to non-mental health difficulties, further 
research is needed to address whether the GAI is able to discriminate between different 
mental health problems.  The significant correlation with the GDS (Diefenbach et al., 
2009) suggests poor discriminant validity thus far. 
GAI-SF.  A recent development has been a short form version of the GAI.  
Byrne & Pachana (2011) recruited 284 female participants aged >60.  The most 
commonly endorsed items of the GAI were investigated in different combinations and 
five items were ultimately chosen to make up the GAI-SF.  The GAI-SF demonstrated 
good internal consistency and was highly correlated with the GAI and somewhat with 
the STAI-State, demonstrating convergent validity.  A strength of the GAI-SF is that it 
did not correlate with age, educational level or MMSE suggesting discriminant validity 
with non-mental health problems.  Similarly to findings with the GAI, the GAI-SF did 
correlate with the GDS, again questioning discriminant validity.  High test-retest 
reliability was found.  The generalisability of these results is limited due to the 
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completely female sample.  These psychometric properties are particularly promising in 
the context of the ease of practical administration and interpretability of the measure.    
GAS.   The psychometric properties of the GAS were considered with a 
community and a clinical sample (Segal et al., 2010). The total GAS score had excellent 
internal consistency with good-excellent alphas for the three subscales.  The GAS also 
demonstrated construct validity, with strong positive relationships between GAS 
subscales and GAS total and each subscale.  The total GAS and subscale scores 
significantly correlated with other anxiety measures suggesting evidence of convergent 
validity; however, discriminant validity was questionable based on the positive 
correlations between the GAS and GDS.  Within the clinical sample, internal 
consistency for the GAS was again good-excellent for the three subscales.  In terms of 
convergent validity, strong positive relationships were demonstrated between the GAS 
total score and each of the 3 subscales.  The GAS total score and subscales significantly 
correlated with the GDS, again questioning discriminant validity. Discriminant validity 
was further tested by correlating the GAS total and subscales with non-mental health 
problems e.g. education, with these results not significant.   
Yochim, Mueller, June & Segal, (2011) further considered the convergent and 
discriminant validity of the GAS.  Discriminant validity was investigated by comparing 
GAS scores to reading ability and processing speed (separate constructs from anxiety).  
OA volunteers from the community completed measures.  Results indicated that the 
GAS had good internal consistency.  The GAS correlated more strongly with both the 
Beck Anxiety Inventory (BAI; Beck, Epstein, Brown & Steer, 1988) and the GAI than 
the BAI and GAI did with each other.  Twenty eight participants scored a BAI score of 
eight or higher (indicative of clinically significant anxiety), these participants scored 
significantly higher on the GAS suggesting that the GAS detected clinically significant 
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anxiety.  However, similar to previous findings, discriminant validity is questionable 
based on the high correlations with two measures of depression.     
One of the notable strengths is that the items of the GAS have been directly 
derived from the DSM-IV.  The GAS correlated more strongly with the GDS than the 
BAI (Yochim et al., 2011); as aforementioned, literature suggests there are strong 
conceptual overlaps between anxiety and depression in this client group.  The GAS did 
demonstrate discriminant validity in relation to non-mental health variables, as 
demonstrated by the lack of correlation with reading ability and processing speed.  The 
development of further data considering cut-off scores and interpretation would be 
clinically useful as well as further exploration of psychometric properties including test-
retest reliability.   
GWS.  The psychometric properties of the GWS and GAI were investigated in 
home-care recipients (Diefenbach et al., 2009).  The term ‘home-care’ in this setting 
refers to individuals who need particular services (e.g. meal delivery, nursing care) to 
support them to continue living in their own homes.  Sixty six OAs were recruited.  In 
addition to the GWS and GAI participants completed a range of anxiety, depression and 
general health questionnaires.  Participants with any anxiety disorder were grouped 
together and compared with individuals without anxiety symptoms who formed the 
control group.  Participants in the anxiety group scored significantly higher on all 
measures apart from the BAI.  All measures (apart for the BAI) also demonstrated a 
moderate effect size.  In terms of convergent validity, the GAI was the strongest and the 
BAI was the weakest.  Discriminant validity was investigated by correlating with the 
GDS.  The GWS significantly correlated with all anxiety measures implying good 
convergent validity, however also correlated with the GDS (greater than with the BAI) 
questioning discriminant validity.  This research also considered the ease of use of 
assessments.  The GWS was found to take less than two minutes to administer on 
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average, with 3% of participants reporting moderate confusion and moderate difficulty 
when completing.  Of all the measures, the GWS and GAI were noted as the least 
frequently reported for problems from clinicians.  Inter-rater reliability was measured 
using audio taped interviews and found to be excellent.  The GWS demonstrates 
promising psychometric properties and is practically useful in terms of administration 
time, scoring and financial implications.   
SAST.  Sinoff et al (1999) recruited 150 geriatric medical inpatients and 
geriatric day-care centre attendees.  All participants underwent a psychiatric evaluation 
and were classified as depressed or non-depressed.    Participants classified as suffering 
from anxiety scored significantly higher on the SAST.  The SAST demonstrated 
acceptable internal consistency, good test-retest reliability, and high levels of 
sensitivity/specificity.  The SAST was specifically investigated among depressed and 
non-depressed participants.  For these groups, the sensitivity and specificity continued 
to be high, with the exception of sensitivity for the non-depressed participants. This 
suggests that the SAST was able to detect both anxiety and depression.  The high 
sensitivity and specificity of the SAST even with a depressed population suggests 
promising results, particularly within OAs where co-morbid anxiety and depression is 
highly prevalent.  The lack of research into the convergent and discriminant validity of 
the measure limits these findings.   
WS.  Wisocki, Handen & Morse, (1986) investigated the efficacy of the WS as 
an anxiety measure in two OA samples.  The first were 54 community dwelling OAs 
and the second were 44 homebound OAs.  Participants completed a range of 
questionnaires in addition to the WS.  Results indicated that both samples reported few 
worries and there were no differences in terms of gender.  Worry was greatest in 
relation to health for both groups and least in relation to social conditions.  The WS 
across both samples correlated with anxiety scores from the Symptom Checklist-90 
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(SCL-90; Derogatis, Rickles & Rock, 1976) and Multiple Affect Adjective Checklist 
(MAACL; Zuckerman, 1960).  The MAACL correlated with the WS in the homebound 
group, but not as highly in the community group.  Significant positive correlations were 
found between health measures and the WS for both samples.  The health worries 
subscale of the WS also significantly correlated with other health measures. Findings 
suggest that the WS has some convergent validity due to the correlations with other 
anxiety measures, but no information with regards to reliability or discriminant validity 
was provided from this research.  There was no attempt to measure whether any 
participants in the research had clinical anxiety, and whether WS scores were reflective 
of this.     
The reliability and validity of the WS was further investigated with individuals 
with GAD (Stanley, Beck & Zebb., 1996). Participants included a sample of 50 OAs 
with GAD and 94 controls.  All participants completed four anxiety measures (WS, 
STAI, Padua Inventory (PI; Sanavio, 1988) and Fear Questionnaire (FQ; Marks & 
Matthews, 1979).  A subtest of the controls were re-administered the questionnaires 
after a two to four week period.  Within the GAD sample, the WS demonstrated 
excellent internal consistency, as well as the total WS score and subscales correlating 
with one another suggesting evidence of construct validity. The weakest correlation was 
between financial worries and total WS score.  The WS significantly correlated with the 
STAI-Trait and PI, demonstrating adequate convergent validity.  The WS also had 
excellent internal consistency for the control group, and demonstrated strong test-retest 
reliability (with the exception of the health subscale).   
Hopko et al., (2000) investigated the relationship between clinician severity 
ratings for GAD and patient self-report measures using the WS.  Sixty four participants 
completed measures.  All anxiety measures significantly correlated with one another, 
apart from WS with the clinician rated GAD severity; this suggests convergent validity 
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amongst self-report anxiety measures.  However, the WS did also significantly correlate 
with a measure of depression, questioning discriminant validity.     
 Stanley et al., (2001) noted the paucity of test-retest reliability and discriminant 
validity data for anxiety measures with OAs and thus tested the WS (the only OA 
specific measure) along with other anxiety measures.  Fifty seven OAs participated in 
the research, all of whom met DSM-IV criteria for GAD.  Participants repeated all 
measures after a 5-20 week period.  Results indicated excellent internal consistency for 
the WS, with subscales within acceptable-excellent ranges.  Test-retest reliability 
indicated adequate stability over time, apart from the social situations subscale.  All WS 
subscales significantly correlated with one another as well as with the total score 
suggesting some evidence of construct validity.  Similar to previous research by 
Stanley, Beck & Zebb (1996), the correlations were weaker with the finances subscale.  
The WS significantly correlated with other measures of worry suggesting evidence of 
convergent validity.  In order to investigate discriminant validity, the WS was correlated 
against two depression measures.  The WS correlated with both depression measures, 
questioning discriminant validity.   
 The WS demonstrates potential with its existing psychometric properties, 
particularly in terms of internal consistency and convergent validity.  Similar to other 
anxiety measures considered throughout the review, the WS lacks discriminant validity 
in relation to depression.  Research does not discuss the scoring of the measure; 
therefore commenting on the practicality for clinicians is limited.  Further research 
should also consider cut-off scores and the sensitivity/specificity of the WS as this 
limits the potential usefulness within clinical practice.      
WSOA-R.  Hunt, Wisocki & Yanko (2003) considered the psychometric 
properties of the WSAO-R.  An OA and younger (student) sample was recruited.  The 
WSAO-R demonstrated excellent internal consistency for both samples.  Within both 
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age groups the WSAO-R subscales correlated with one another, as well as with the 
totals score and another measure of worry, suggesting evidence of construct and 
convergent validity.  Overall, the results of the WSOA-R suggested a trend towards 
OAs reporting greater worry; however these results were not significant.  In terms of 
coping strategies, younger adults reported a greater number than OAs.  The WSOA-R 
lacks evidence of discriminant validity, test-retest data and sensitivity/specificity.  There 
is also limited practical information for clinicians (e.g. cut-off scores, time taken to 
complete or complexity of scoring).  As this is the longest of the measures reviewed, 
such information could potentially influence practical use of the measure in clinical 
settings.  Further research should also consider the psychometric properties of the 
WSOA-R with a clinical sample. 
Methodological Critique of the Evidence Base 
Research within this review shares methodological limitations such as the 
common lack of clinical samples (e.g. Lowe & Reynolds, 2006; Lowe & Reynolds, 
2000; Yochim et al., 2011).  There were also examples of participant selection bias such 
as using participants who were rewarded financially (Stanley et al., 1996), volunteers 
(Yochim et al., 2011), or students and family members (Segal et al., 2010).  Across 
research, there is a theme of ethnic homogeneity, with most research predominantly 
recruiting Caucasian participants (e.g. Pachana et al., 2007 Matheson et al., 2012; 
Yochim et al., 2011).  It should also be considered that all the research was conducted in 
USA, Australia, New Zealand or Israel, questioning applicability within the UK.  There 
is a recurring theme of somatic items being confused with poor physical health 
symptoms for OAs.  This highlights the need to assess medical problems in OAs, which 
was not consistently done across studies (e.g. Segal et al., 2010).  Another inconsistency 
across the studies was whether participants were assessed for cognitive impairment or 
not.  Despite these limitations, several strengths should also be noted such as validating 
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measures with clinical as well as community samples (e.g. Pachana et al., 2007; Segal et 
al., 2010), diagnosing clinical anxiety by staff with extensive training (e.g. Hopko et al., 
2000) and taping diagnosis interviews to assess for inter-rater reliability (e.g. Stanley et 
al., 1996).   
Psychometric Properties 
 A consistent theme amongst measures was the lack of discriminant validity.  
Although evidence of discriminant validity was found with non-mental health problems 
(e.g. Byrne & Pachana, 2011; Segal et al., 2010; Yochim et al., 2011), this was not 
evident with depression (e.g. Hopko et al., 2000; Stanley et al., 2001, Diefenbach et al., 
2009; Segal et al., 2010 & Yochim et al., 2011).  Segal et al., (2010) discuss the overlap 
between the constructs of anxiety and depression within OAs, and suggested positive 
correlations with depression measures may be representative of co-morbidity. Krasucki, 
Howard & Mann (1999) argue that distinguishing between anxiety and depression in 
late-life may not be feasible, as co-occurrence is reflective of the convergence of 
anxiety and depression for OAs.  Another noteworthy issue was the use of non-OA 
specific anxiety measures to investigate convergent validity.  Although the measures 
used may have been validated with OAs, they were not developed for this age group.  
More comparable constructs may be other OA specific measures, as investigated with 
the GAS and AMAS-E (Segal et al., 2010), GAS and GAI (Yochim et al., 2011) and 
GWS and GAI (Diefenbach et al., 2009).  
Practical Implications 
 All measures apart from the AMAS-E were available without charge.  This 
could be important in terms of practicality for clinicians.  Also, all measures were 
classified as ‘easy’ to score (items summed together) and reported as taking between 2-
15 minutes to complete.  The WS does not have information about scoring and the 
WSOA-R does not have information about scoring or administration time.  Those 
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measures with cut-off scores (e.g. GAI, GAI-SF, GWS & SAST) provide context for 
clinicians when interpreting results.   
Conclusions 
Overall there is a dearth of anxiety measures designed specifically for use with 
OAs.  From the literature that is available, the GAI had the most evidence for validity, 
reliability, sensitivity and specificity with community and clinical samples.  Cut-off 
scores and consideration of practical burden as well as being freely available means the 
GAI has clinical utility.  The GAI-SF also showed promising psychometric properties, 
however further research beyond the initial validation study would be useful.  Similarly, 
the GWS demonstrated positive psychometric foundations and practical implications, 
however has only been validated within one piece of research.  The AMAS-E, GAS and 
WS all shared some common psychometric properties (e.g. excellent internal 
consistency).  Despite this, they all lacked investigation of sensitivity/specificity and 
therefore do not have cut-off scores, limiting practical usage.  In addition, the GAS also 
lacked test-retest information and the AMAS-E must be purchased which may limit its 
usage.  The SAST and WSOA-R both lacked validation research to extensively 
comment on their robustness.  The SAST has some positive findings in relation to 
sensitivity and specificity; however, further research is needed to be able to comment on 
convergent and discriminant validity.  The WSOA-R is the longest measure reviewed, 
however the lack of information about practical burden means commenting on how this 
was received by OAs is unknown.  There is also further investigation needed of the 
responsiveness and test-retest reliability of the WSAO-R.   
  Future Research 
 There are definite areas for further research highlighted from the review.  Firstly, 
further validation of the existing OA specific measures particularly with regard to 
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discriminant validity with other mental health problems, validation amongst different 
clinical groups, and validation with more diverse groups in terms of ethnicity. 
 Secondly, there is scope to develop other measures of anxiety designed 
specifically with OAs.  More measures in this field would increase the choice for 
clinicians and service users to find measures that suit the individual.  Overall, further 
validation of OA specific anxiety measures would provide a more robust evidence base 
and more information about clinical utility with this client group. 
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Table 4. 
 
Overview of the Practical Implications of Each Measure 
 
Measure   Interpretability   Practical Burden   Financial 
  
 
Domains 
No. 
Of 
Items 
No. of Response 
Options 
Range 
of 
Scores  Cut off scores 
 
Time 
taken to 
complete 
(mins) 
Complexity 
of scoring
a
   Cost 
AMAS - 
E 
 fear of aging, 
physiological anxiety, 
worry/oversensitivity 
44 2  
(yes/no) 
0 - 44 x 5-10 Easy  $55 plus costs 
of forms 
($39.50 per 
pack of 20) 
purchasable 
from internet 
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Measure   Interpretability   Practical Burden   Financial 
  
 
Domains 
No. 
Of 
Items 
No. of Response 
Options 
Range 
of 
Scores  Cut off scores 
 
Time 
taken to 
complete 
(mins) 
Complexity 
of scoring
a
   Cost 
GAI  symptoms of anxiety - 
less focus on somatic 
items  
20 2  
(agree/disagree) 
0 - 20 >11                      
(GAD)                             
>9                           
(any anxiety 
disorder or 
depressed sample)                             
>7                                 
(Parkinson's Disease 
sample)  
5-10 Easy  Free from GAI 
website 
            
GAI - SF  symptoms of anxiety - 
less focus on somatic 
items  
5 2 
(agree/disagree) 
0 - 5 >3  2-5 Easy  Free from 
author 
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Measure   Interpretability   Practical Burden   Financial 
  
 
Domains 
No. 
Of 
Items 
No. of Response 
Options 
Range 
of 
Scores  Cut off scores 
 
Time 
taken to 
complete 
(mins) 
Complexity 
of scoring
a
   Cost 
GAS  somatic, cognitive, 
affective 
30 4 point scale  
(not at all, 
sometimes, most 
of 
the time, all of 
the time) 
0 - 75 x 10 Easy  Free from 
author 
            
GWS  cognitive and affective 
symptoms of anxiety 
5 2     
(yes/no) 
0-5 > 2                                                
> 4 (GAD) 
2 Easy  Free from 
author 
            
SAST  symptoms of anxiety - 
including somatic items  
10 4 point scale 
(rarely or never, 
sometimes, often, 
always) 
0-40 > 24  10-15 Easy  Free from 
internet 
            
WS  worry in relation to 
finances, health & social 
conditions 
35 5 point scale 
(never, rarely, 
sometimes, often, 
much of the time) 
0-140 x  2-5 x  Free from 
author 
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Measure   Interpretability   Practical Burden   Financial 
  
 
Domains 
No. 
Of 
Items 
No. of Response 
Options 
Range 
of 
Scores  Cut off scores 
 
Time 
taken to 
complete 
(mins) 
Complexity 
of scoring
a
   Cost 
WSOA-R   finances, health, social 
conditions, personal 
concerns, family 
concerns, and world 
issues 
88 5 point scale 
(never, rarely, 
sometimes, often, 
much of the time) 
0-352 x  x x   Free from 
author 
 
 
                                                             
a
 Based on criteria set by Bot et al., (2003) Easy = summed items, Moderate = simple formula, Difficult = complex formula 
x = Information unavailable 
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Table 5. 
Psychometric Properties of Measures 
Measure   Reliability   Validity   Responsiveness 
   Internal 
Consistency                             
( ) 
Test-retest    
(Pearson's r)
Inter-rater   
(Pearson's r) 
 Convergent                     
Significant 
Intercorrelations (r) 
Discriminant 
Correlations (r) 
 Sensitivity     
% 
Specificity      
% 
AMAS-E Lowe & 
Reynolds 
(2006)        
.90 
Lowe & 
Reynolds 
(2006)          
.91 
x  Lowe & Reynolds 
(2006)                   
STAI-T .65 
Lowe & 
Reynolds (2006)            
STAI-S .39 
 x x 
  Lowe & 
Reynolds 
(2003)       
.71-.92 
Lowe & 
Reynolds 
(2003)          
.83 
       
  Lowe & 
Reynolds 
(2000)       
.91-.92                       
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Measure   Reliability   Validity   Responsiveness 
   Internal 
Consistency                             
( ) 
Test-retest    
(Pearson's r)
Inter-rater   
(Pearson's r) 
 Convergent                     
Significant 
Intercorrelations (r) 
Discriminant 
Correlations (r) 
 Sensitivity     
% 
Specificity      
% 
GAI  Byrne et al., 
(2010)           
.92 
Diefenbach et 
al., (2009)            
.95 
Diefenbach 
et al., (2009)              
1.0 
 Byrne et al., (2010)         
NEO FFI .57               
STAI-S .58 
Diefenbach et 
al., (2009)           
GDS .79 
 Cheung et 
al., (2012)       
85.7 
Cheung et 
al., (2012)           
78 
 
  Cheung et 
al., (2012)            
.92 
Matheson et 
al., (2012)          
Spearman's 
Rho .99 
Pachana et 
al., (2007)               
.99 
 Cheung (2007)                
GAS .82                       
STAI .69 
 
  Diefenbach 
et al., (2009)   
87.5  
Diefenbach 
et al., (2009)        
95.5 
  Diefenbach 
et al., (2009)            
.93       
 
Pachana et al., 
(2007)          
.91 
  Diefenbach et al., 
(2009)                
GADQ-IV .65              
PSWQ .79                 
PSWQ-A .79                 
BAI .61                      
BMWS .77               
GADSS .83                 
GWS .86 
 
Matheson et al., (2012) 
STAI .69 
 
Pachana et al., (2007) 
STAI-S .80 
GAS .70 
  Matheson et 
al., (2012)       
87.5 
 
Pachana et 
al., (2007)  
73 - 75 
 
 
 
 
 
 
 
 
Matheson et 
al., (2012)        
85.7 
 
Pachana et 
al., (2007) 
80 - 84 
      
Matheson et 
al., (2012)           
.95      
                                
Pachana et 
al., (2007)            
.91-.93 
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Measure   Reliability   Validity   Responsiveness 
   Internal 
Consistency                             
( ) 
Test-retest    
(Pearson's r)
Inter-rater   
(Pearson's r) 
 Convergent                     
Significant 
Intercorrelations (r) 
Discriminant 
Correlations (r) 
 Sensitivity     
% 
Specificity      
% 
GAI - SF  Byrne &  
Pachana  
(2011)        
 .81 
Byrne & 
Pachana 
(2011)   
Spearman's 
Rho .80 
x  Byrne & Pachana 
(2011)                      
GAI .88                       
STAI-S .48 
Byrne & 
Pachana (2011)                   
GDS .37                    
MMSE -.04            
Education -.08 
 Byrne & 
Pachana 
(2011)            
75 
Byrne & 
Pachana  (2011)                                    
87                         
    
           
GAS  Segal et al., 
(2010)            
.93 
x x  Segal et al., (2010)          
STAI-T .79                    
STAI-S .74                    
BAI .82                         
AMAS-E .77 
Segal et al., 
(2010)             
Education -.01 
GDS .78 
 x x 
  Yochim et 
al., (2011)          
.90 
   Yochim et al., (2011)       
GAI .69                         
BAI .61       
Yochim et al., 
(2011)            
WAIS-CD -.22           
WTAR -.36         
GDS .74             
BDI-II .73 
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Measure   Reliability   Validity   Responsiveness 
   Internal 
Consistency                             
( ) 
Test-retest    
(Pearson's r)
Inter-rater   
(Pearson's r) 
 Convergent                     
Significant 
Intercorrelations (r) 
Discriminant 
Correlations (r) 
 Sensitivity     
% 
Specificity      
% 
GWS  Diefenbach 
et al., (2009)           
.78 
Diefenbach 
et al., (2009) 
.85 
 
 
 
 
Diefenbach 
et al., (2009) 
1.0 
 Diefenbach et al., 
(2009)   
GADQ-IV .67            
PSWQ .67                  
PSWQ-A .66                  
BAI .50                     
BMWS .72                
GADSS .70                    
GAI .86 
Diefenbach et 
al., (2009)            
GDS .55 
 Diefenbach 
et al., (2009) 
.88 
Diefenbach 
et al., (2009) 
74 
           
           
SAST  Sinoff et al., 
(1999)           
.70 
Sinoff et al., 
(1999)            
.73 
Sinoff et al., 
(1999)      
Kappa .71 
 x x  Sinoff et al., 
(1999)      
75.4 
Sinoff et al., 
(1999)         
78.7 
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Measure   Reliability   Validity   Responsiveness 
   Internal 
Consistency                             
( ) 
Test-retest    
(Pearson's r)
Inter-rater   
(Pearson's r) 
 Convergent                     
Significant 
Intercorrelations (r) 
Discriminant 
Correlations (r) 
 Sensitivity     
% 
Specificity      
% 
WS  Stanley et 
al., (2001)         
.93 
Stanley et al., 
(2001)            
.70 
x  Hopko et al., (2000)                            
PSWQ .56                     
STAI-T .55                     
Hopko et al., 
(2000)                 
BDI .52 
 x x 
  Stanley, 
Beck & 
Zebb (1996)                            
.94 (NC) 
Stanley, Beck 
& Zebb 
(1996)       
Correlation 
Coefficient 
.69 
  Stanley et al., (2001)        
STAI-S .33                       
STAI-T .55                  
PSWQ .54                       
Stanley et al., 
(2001)                  
BDI .54                
GDS .41 
   
  Stanley, 
Beck & 
Zebb (1996)                            
.93 (GAD) 
   Stanley, Beck & Zebb 
(1996)                                                      
(GAD) STAI-T .40                     
(GAD) PI .46               
(NC) STAI-S .41               
(NC) STAI-T .57           
(NC) PI .50                                    
    
      Wisocki et al (1986)      
(CA) SCL-A .54              
(CA) MAACL-A .24          
(HB) SCL-A .62                
(HB) MAACL-A .71 
    
           
OLDER ADULT ANXIETY MEASURES: A SYSTEMATIC REVIEW    45 
 
Measure   Reliability   Validity   Responsiveness 
   Internal 
Consistency                             
( ) 
Test-retest    
(Pearson's r)
Inter-rater   
(Pearson's r) 
 Convergent                     
Significant 
Intercorrelations (r) 
Discriminant 
Correlations (r) 
 Sensitivity     
% 
Specificity      
% 
WSOA-
R 
  Hunt et al., 
(2003)               
.97 
x x   Hunt et al., (2003)             
PSWQ .45 
x   x x 
 
 
Note.  AMAS-E=Adult Manifest Anxiety Scale-Elderly, BAI=Beck Anxiety Inventory, BDI=Beck Depression Inventory, BDI-II=Beck Depression 
Inventory-II, BMWS=Brief Measure of Worry Severity, CA=Community Active, GAD=Generalised Anxiety Disorder, GADSS=Generalised Anxiety 
Disorder Severity Scale, GBAS=Goldberg Anxiety Scale, GADQ-IV=Generalised Anxiety Disorder Questionnaire for DSM-IV, GAI=Geriatric 
Anxiety Inventory, GAI-SF=Geriatric Anxiety Inventory-Short Form, GAS= Geriatric Anxiety Scale, GDS=Geriatric Depression Scale, 
GWS=Geriatric Worry Scale, HADS=Hospital Anxiety & Depression Scale, HB=Homebound, MAACL-A=Multiple Affect Adjective Checklist-
Anxiety, MMSE-Mini Mental State Examination, NC=Normal Control, NEO-FFI=NEO Five-Factor Inventory, PI=Padua Inventory, PSWQ=Penn 
State Worry Questionnaire, PSWQ-A= Penn State Worry Questionnaire-Abbreviated, SAST=Short Anxiety Screening Test, SCL-A=Symptom 
Checklist-Anxiety, STAI=State Trait Anxiety Inventory, STAI-S=State Trait Anxiety Inventory-State, STAI-T=State Trait Anxiety Inventory Trait, 
WAIS-CD=Wechsler Adult Intelligence Scale-Coding, WTAR=Wechsler Test of Adult Reading, WS=Worry Scale, WSOA-R=Worry Scale for Older 
Adults-Revised.
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Abstract 
 
Purpose.  There is a dearth of literature in relation to group interventions that address 
co-morbid anxiety and depression for older adults. This research evaluated the clinical 
effectiveness of a manualised six session cognitive behavioural psychoeducational 
group programme for older adults.       
Design.  A pre-post and short term follow up design was used.   
Method.  Patients (N=34) meeting specified inclusion criteria attended a group (N=8).  
A battery of process and outcome measures, Hospital Anxiety and Depression Scale 
(Zigmond & Snaith, 1983), Clinical Outcomes in Routine Evaluation – Outcome 
Measure (CORE-OM; Barkham et al., 1998) and Health of the Nation Outcome Scale 
65+ (Burns et al., 1999) were completed at assessment, termination and six week follow 
up.  Patients rated therapy alliance using the Group Session Rating Scale (Duncan & 
Miller, 2007) following each session.  
Results.  All outcome measures demonstrated improvement in assessment to 
termination and assessment to follow up comparisons.  On the CORE-OM, 28% of 
patients reliably improved and 22% were classified as recovered at termination.   
Conclusions.  The current research considered the management of mixed anxiety and 
depression with older adults via a group cognitive behavioural therapy intervention.  
The intervention shows promising findings with anxiety, depression, psychological 
well-being and staff observation ratings of patient well-being, all improving following 
intervention.  Methodological limitations and directions for future research are 
identified and discussed.       
 
Keywords: older adult, CBT, group, anxiety, depression, psychoeducation. 
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Depression and anxiety co-occur at high rates in older adult populations;   
Beekman et al., (2000) found that 47.5% of those with major depressive disorder had 
co-morbid anxiety disorders and 26.1% of people with anxiety disorders had co-morbid 
major depressive disorders.  Katona, Manela and Livingstone (1997) found high rates of 
co-morbid generalised anxiety disorder (GAD) in older adults diagnosed with 
depression and Flint (1999) noted that late-life GAD was typically associated with 
depression.  Co-morbidity in older adults is twice more likely in women than men, with 
more severely depressed individuals more likely to suffer with severe anxiety and vice 
versa (Schoevers, Beekman, Deeg, Jonker & van Tilburg, 2003).     
For the treatment of anxiety and depression in working age adults, the National 
Institute for Clinical Excellence (NICE) recommends Cognitive Behavioural Therapy 
(CBT; 2004a & 2004b).  Whilst group CBT is also recommended by NICE for working 
age adults (NICE Guideline 90, 2009) there are no specific guidelines in relation to 
older adults.  Despite the evidenced overlap between anxiety and depression in older 
adults, there is a dearth of literature investigating the effectiveness of group CBT for the 
management of such co-morbid difficulties.  Payne and Marcus (2008) reviewed the 
efficacy of group psychotherapy in older adults across 44 studies and concluded CBT 
was more effective than reminiscence therapy.  There are a number of age specific 
challenges in providing group therapy including sensory deficits, transportation to group 
and fears of being around other older/disabled persons (Agronin, 2009).   
CBT Groups for Depression 
A recent systematic review of older adult group CBT for depression concluded 
that the approach is effective (Krishna et al., 2011), and highlighted six CBT 
randomised controlled trials (RCTs).  All CBT was delivered via weekly group therapy, 
with treatment duration varying from eight (Kunik, et al., 2008), 10 (Rokke et al. 2000), 
11 (Klausner et al., 1998), 12 (Arean et al., 1993, Hautzinger & Welz, 2004), and 24 
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weeks (Abraham et al., 1992).  Although the results indicated CBT based group 
interventions were effective when compared to waiting list controls, results were not 
statistically superior to other active interventions e.g. reminiscence, educational, or 
group visual imagery. 
A further four RCTs have considered the efficacy of CBT groups for depression.   
A trial with nursing home residents found that patients in group CBT (13 sessions, twice 
weekly) demonstrated statistically significant improvement when compared to treatment 
as usual (TAU; Konnert, Dobson & Stelmach, 2009).  Similarly, a CBT depression 
management intervention (10 weekly sessions) demonstrated a significant decrease in 
depressive symptoms when compared to waiting list controls (Haringsma, Engels, 
Cuijpers & Spinhoven, 2006).  Arean et al., (2005) compared group CBT (18 sessions 
over 6 months), clinical case management and a combination of both.  A combination of 
case management and group CBT resulted in significantly lower depression symptoms 
and group CBT improved physical functioning more than case management alone or a 
combination of both.  Wilkinson et al’s (2009) pilot trial reported mixed findings when 
patients were randomised to eight group sessions of CBT/antidepressant condition or 
antidepressant alone.  Although depression scores were lower for the group CBT 
condition, these findings were not significant.   
Four pieces of practice-based research (Barkham, Stiles, Lambert & Mellor-
Clark, 2010) have considered group CBT with comparative treatments, but did not 
randomise patients.  Beutler et al. (1987) compared the following treatments: (a) 
medication and support, (b) placebo and support, (c) group CBT (20 weekly sessions), 
placebo and support or (d) group CBT, medication and support.  ‘Support’ was defined 
as 20-30 minute weekly sessions to note side effects and adjust medication.  Findings 
indicated that the CBT patients reported improvements in sleep hygiene and patients 
were less likely to drop out.  Steuer et al., (1984) compared group CBT with 
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psychodynamic group psychotherapy (46 sessions over nine months).  Patients in both 
groups showed clinically significant reductions for depression and anxiety, with 
treatment comparisons favouring the CBT intervention.  Cappeliez (2000) tracked the 
intensity of depression during weekly group CBT for 12 weeks, finding a gradual 
decrease in depressive symptoms.  Nance (2012) described a nurse led group over 12 
weekly sessions, finding that patients’ outcome measures indicated mild to moderate 
improvement for depression and overall improvements in personal growth, changing 
negative thoughts and relationships with family.  
The extant evidence base suggests that group interventions for older adults can 
be beneficial in managing depression, particularly when compared with control 
conditions.  However, the literature is too sparse to provide conclusive evidence, 
especially in relation to whether CBT groups are the most beneficial form of therapy in 
comparison to other active treatments. 
CBT Groups for Anxiety Disorders 
The most common disorder treated with group CBT for older adults is GAD 
with the evidence base consisting of three RCTs.  Stanley, Beck and DeWitt Glassco 
(1996) compared CBT (14 weekly group sessions) and non-directive group supportive 
therapy.   Whilst both methods created significant improvements to anxiety, there were 
no significant differences evident between treatments.  Wetherell, Gatz and Craske 
(2003) found CBT groups (12 weekly sessions) and discussion groups created greater 
improvement in GAD than waiting list control.  Again, there were no significant 
differences between treatments.  Stanley et al., (2003) compared group CBT (15 weekly 
sessions) with a minimal contact group (phone contact).  Findings indicated a 
significant improvement of anxiety, worry, depression and quality of life following 
CBT and these improvements were maintained at one year follow-up.  Wetherell et al., 
(2005) pooled data from these three RCTs and found approximately half of patients 
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achieved a significant pre-post reliable change.  Better outcomes were associated with 
greater adherence to homework and higher baseline anxiety.   
In terms of practice-based evidence, Radley, Redston, Bates, Pontefract and 
Lindesay (1997) conducted a small study (N=6) where patients acted as their own 
controls prior to attending eight weekly CBT treatment sessions.  They found CBT 
treatment was associated with a significant reduction in anxiety symptoms in two of 
their three outcome measures.  Similarly to the research in this field relating to 
depression, it does appear that group CBT is beneficial in managing anxiety with this 
client group.  
CBT Groups for Anxiety and Depression 
Much less empirical attention has focussed on group CBT treatment of mixed 
anxiety and depression, as only a single study has been conducted.  Schimmel-Spreeuw, 
Linssen and Heeren (2000) devised a ‘coping with depression and anxiety course’ (20 
weekly sessions) with outpatient elderly depressed women, to increase knowledge by 
psychoeducation and skills training.  Findings indicated that 53.1% of patients who 
completed the basic module reported that their knowledge of anxiety and depression had 
improved.  A statistically significant decline in depression, anxiety and neuroticism 
from pre to post treatment and at follow-up was found.   
Clearly literature in relation to group interventions that address co-morbid anxiety 
and depression for older adults is sparse, despite this being a highly prevalent clinical 
issue with this population (Cairney, Corna, Velhuidzen, Herrmann & Streiner, 2008).  
Considering such prevalence, evaluations of group interventions is potentially clinically 
and economically useful. The present research therefore presents a feasibility study 
considering the effectiveness of a manualised group CBT intervention with older adults 
in reducing anxiety and depression.  The study adopts a pragmatic, naturalistic design.  
The rationale for this is that naturalistic designs have high external validity (Hotopf, 
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2002), with patients representative of routine clinical practice, treated in a setting that 
they would have experienced as part of their care.  This is an innovative piece of 
research as it is one of the only known manualised group CBT interventions addressing 
both anxiety and depression with older adults.  To address the gender bias in the 
Schimmel-Spreeuw et al., (2000) study, the group was open to both male and female 
older adult patients.  As this is a feasibility study, the practicality of undertaking further 
research will also be considered.          
Aims  
1. To investigate whether a manualised CBT psychoeducational group for mixed 
anxiety and depression is clinically effective.  
   1.2.  To investigate whether improvements are maintained at follow-up. 
The two secondary aims as follows:- 
2. Whether attendance has any effect on psychological well-being and staff 
members’ observation of a patient’s well-being. 
3. To examine the perceived group therapy alliance, and self reported anxiety and 
depression, following each session. 
 Hypotheses 
In relation to the primary aim, hypotheses are as follows: 
1. Patients will report reduced anxiety and depression following treatment, in 
comparison to assessment.   
1.2 Reductions to anxiety and depression scores will be maintained at follow-up. 
In relation to the secondary aims, hypotheses are as follows: 
2. Patients will report improved psychological well-being following treatment and 
at follow-up in comparison to assessment.  Staff will observe an improvement in 
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patients’ well-being following treatment and at follow-up in comparison to 
assessment. 
3. Patients will report increased therapy alliance and reductions in self reported 
anxiety and depression across weekly therapy sessions. 
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Method 
Sample  
A total of 41 patients were recruited, with 34 completing treatment (seven were 
lost to attrition).  Figure 1 details patient flow through the research.  Completers were 
aged between 66 to 95, with a mean age of 74.8 (SD=7.5), 82% were females (N=28) 
and 97% (N=33) prescribed medication for their anxiety/depression.  All patients were 
white British.  Marital status was classified as 50% married (N=17), 15% divorced 
(N=5), 32% widowed (N=11) and 3% single (N=1).  Original reason for referrals were 
18% anxiety (N=6), 20% depression (N=7) and 62% mixed anxiety and depression 
(N=21).  Demographic information of patients is reported in Table 1.       
Patients were recruited from a secondary mental health service in a large 
Northern city in the UK.  This included community mental health teams (four separate 
teams that cover across the city), psychiatric outpatients, day hospitals, and inpatient 
wards (two wards that cover the city).  Mental health professionals across older adult 
services were made aware of the intervention, ensuring referrals to the group were 
appropriate.   
Inclusion criteria for the study were, (1) individuals were over 65 years of age, 
(2) already have contact with secondary mental health services, (3) been assessed as 
having anxiety, depression or mixed anxiety/depression as their primary difficulty, (4) 
potentially able to make use of a psychoeducational approach  and (5) be willing to 
attend a group for six weeks.  The exclusion criteria were, (1) if either anxiety or 
depression was not the individual’s primary reason for referral, (2) if the individual had 
an insufficient understanding of English and (3) presence of significant cognitive 
impairment. 
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Figure 1.  Patient Flow Chart through Research  
 
Measures 
Patients completed a battery of psychometric assessments at three time points; 
assessment (prior to intervention), termination (end of intervention) and follow-up (six 
weeks following end of intervention).  Assessment and termination were administered 
to patients either within the group or through the patient’s usual clinical contact with the 
service.  If this was not possible, patients were either visited by the Chief Investigator at 
a mutually convenient time or assessments were sent by post with pre paid envelopes 
for return.  This was also the method for follow-up data collection.  The following 
measures were administered. 
Primary outcome measure: Hospital Anxiety & Depression Scale (HADS; 
Zigmond & Snaith, 1983).  The HADS (Appendix B1) measures anxiety and 
Did not consent to 
research (N = 5) 
 
Eligible for group (N = 46) 
Began attending group and 
consented to research (N = 41) 
Total Sample (N = 34) 
Withdrew from group 
and research (N = 7) 
(2 unwell with 
physical health 
problems, 5 reasons 
not stated) 
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depression over 14 items, over the last week.  Anxiety and depression scores range from 
0 – 21 and a higher score indicates greater severity.  All items are rated on a four point 
scale.  HADS scores of < 8 for either subscale are sub-clinical, scores between 8 – 10 
indicate ‘mild anxiety and/or depression’ and scores >11 indicate anxiety and 
depression ‘caseness’.  The HADS has good concurrent validity (Zigmond & Snaith., 
1983; Bjelland, Dahl, Haug & Neckelmann, 2002), internal consistency (Bjelland et al., 
2002) and  test retest reliability (Spinhoven et al., 1997).  
Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM; 
Barkham et al., 1998).  The CORE-OM (Appendix B2) is a 34 item measure of global 
psychological distress, with subscales of subjective well-being, functioning, 
psychological problems and risk.  Items are scored on a five point scale from 0 – 4 and a 
higher score is indicative of greater distress.  The CORE-OM has shown good 
reliability, validity against longer and less general measures, and has been shown to be 
sensitive to change (Evans et al., 2000).  The CORE-OM has been found to be a reliable 
and structurally sound measure to use with older adults and a lower clinical cut-off of 
0.952 has been suggested for this client group (Barkham, Culverwell, Spindler & 
Twigg., 2005).   
Health of the Nation Outcome Score (HoNOS 65+; Burns et al., 1999).  The 
HoNOS 65+ (Appendix B3) is a clinician rated measure of different health and social 
domains.  Twelve single item scales measure various aspects of mental and social health 
each on a five item scale from 0 - 4. The HoNOS 65+ has been reported as ‘easy’ to 
administer, has moderate concurrent validity and good inter-rater reliability, (Spear, 
Chawla, O’Reilly, & Rock., 2002).  It has also evidenced good criterion validity and 
content validity, (Shergill, Shankar, Seneviratna, & Orrell., 1999).   
Group Session Rating Scale (GSRS; Duncan & Miller, 2007).  The GSRS 
(Appendix B4) is a four item rating scale measuring group therapy alliance.  The scale 
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is based upon the Session Rating Scale which is used within one to one sessions and has 
demonstrated high levels of reliability (Duncan et al., 2003).Group patients rate the 
‘relationship’ aspect of the group, whether their ‘goals and topics’ were addressed, the 
facilitators ‘approach and method’, and their ‘overall’ view of the group.  The GSRS 
uses a 0-10 visual analogue scale and responses are summed together out of a possible 
score of 40 (higher scores indicative of a more positive group therapy alliance).  The 
GSRS has been found to have excellent internal consistency and good concurrent 
validity, (Miller & Duncan, in press).  An additional two questions (0-10 visual 
analogue scales) were added to the GSRS asking patients to rate current levels of 
anxiety and depression.  This provided data relating to the patient’s mood each week (a 
higher response being indicative of improved mood and decreased anxiety). 
Design  
Patients were given an information sheet (Appendix C1) about the research, and 
completed a consent form (Appendix C2) prior to intervention.  Outcome measures 
(HADS, CORE-OM, HoNOS 65+) were collected at three time points, assessment 
(prior to group intervention), termination (end of group intervention) and follow-up (six 
weeks following group intervention).  Patients attended the six week Anxiety and 
Depression Management Group as soon as a place was available.  As groups were 
regularly run over the data collection period, wait-time was never longer than four 
weeks.  At the end of each group session, patients completed the GSRS and rated 
current anxiety and depression.  During the group, patients continued to receive 
treatment as usual from secondary mental health services.  Demographic and medication 
information was recorded at all time points.  Service users were able to attend the 
groups even if they did not wish to take part in the research.  Eight nine percent (N=41) 
of referrals to the group also consented to the research.  Eight groups were run over the 
data collection period (group size range 4 – 7).   
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Intervention 
The group intervention was based on the theoretical model of CBT (Beck, 1976) 
which focuses on the relationship between an individual’s physical symptoms, thoughts, 
behaviours and mood.  CBT has proven to be efficacious with older people (Laidlaw, 
Thompson, Dick-Siskin & Gallagher-Thompson, 2003, p.16).  Zeiss & Steffen (1996) 
suggest a number of adaptations to CBT when working with an older client group, 
including slower pacing, multimodal training and memory aids such as written 
information.  The Anxiety and Depression Management Group Manual was written in 
accordance with such guidance.  The intervention is structured to provide 
psychoeducation about anxiety and depression, use behavioural and cognitive change 
methods e.g. activity scheduling, relaxation and thought challenging.  The intervention 
uses a multimodal approach (e.g. visual information, role play, between session work).  
The manual can be seen in Appendix D.   
The intervention was facilitated by three clinicians in every group; a facilitator, co-
facilitator and observer (roles were rotated as clinicians felt appropriate).  All 
disciplines of staff were invited to facilitate the groups, and training days were offered 
by the Chief Investigator and NHS Supervisor.  Groups were facilitated by clinical 
psychologists, trainee clinical psychologists, mental health nurses, occupational 
therapists and student occupational therapists.  Two pilot groups had been run using the 
Anxiety and Depression Management Manual prior to data collection, which 
highlighted some minor changes to the manual in its current form e.g. order of 
information and simplification of language. 
Intervention Integrity and Risk Management 
The Anxiety and Depression Management Group intervention was manualised 
and therefore facilitators followed the manual.  Fidelity was monitored through group 
supervision from the NHS Supervisor.  The observer in each session monitored whether 
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key themes were covered each week by using checklists (Appendix E1) which detailed 
the core components of each session.  The intervention was delivered by mental health 
professionals who had access to the mental health records of patients and line 
management to support them with any issues of risk.  Facilitators were also provided 
with an adverse incident form (Appendix E2) to be completed should any issues arise.  
Facilitators had access to General Practitioners and Psychiatrists to share any pertinent 
risk information.   
Ethics 
The research proposal underwent scientific review at the University of Sheffield 
and received a favourable ethical opinion from the National Research Ethics Service in 
June 2011 (Appendix F1), as well as research governance approval from Sheffield 
Health and Social Care NHS Foundation Trust Research Development Unit (Appendix 
F2).   
Data Analysis Strategy 
Statistical analyses were conducted using the SPSS Software (PASW version 18 
for Windows).  Independent samples t-tests compared HADS, CORE-OM and HoNOS 
65+ between completers and non-completers.  For the investigation of the primary aim, 
an uncontrolled effect size (Cohen’s d) with 95% confidence intervals, was calculated 
by subtracting the mean termination figure from the assessment figure and dividing this 
by the assessment standard deviation (Barkham, Gilbert, Connell, Marshall & Twigg, 
2005; Westbrook & Kirk, 2005).  Cohen (1988) defines three values for d: small (0.20), 
medium (0.50) and large (0.80).  The effect sizes of extant research considering anxiety 
and depression CBT groups with older adults were also calculated using this formula, to 
provide benchmarking information for the current findings.  This was repeated for the 
assessment to follow-up data.  Paired samples t-tests assessed the mean difference from 
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assessment to termination, termination to follow-up and assessment to follow-up on the 
HADS, CORE-OM and HoNOS 65+.   
Reliable and clinical significant change (RCSC) rates were calculated on the 
HADS and CORE-OM from assessment to termination and assessment to follow-up.  
The Reliable Change Index (RCI; Jacobson & Truax, 1991) is used to assess the degree 
of clinical change beyond what could be deemed as measurement error (Jacobson & 
Truax, 1991).  As there is no published RCI for the HADS, this was calculated using the 
means and standard deviation from the current study, and the test-retest figures from a 
published piece of research considering the validation of the HADS (Spinhoven et al., 
1997).  Calculating significant clinical change entails also using the clinical cut-off 
between clinical and non-clinical populations; consideration of clinical change alone 
may inflate recovery rates as a patient may move from being clinical to non-clinical but 
within the boundaries of measurement error. Therefore the RCSC considers both 
reliable and clinical change contemporaneously and denotes whether ‘recovery’ has 
been achieved.   
The rates of ‘recovery’ are dependent upon the number of patients scoring 
within the clinical range at assessment, for those not within the clinical range at 
assessment, it is impossible to achieve clinically significant improvement to a non-
clinical population, (Barkham, Stiles, Connell & Mellor-Clark, 2011).  Therefore, 
‘recovery’ is calculated using the number of patients demonstrating RCSC as a 
proportion of those scoring within the clinical range at assessment.  In addition to 
improvement, deterioration was assessed by using the same principles.  The rates of 
‘harm’ are dependent upon the number of patients non-clinical at assessment, for those 
individuals classified as clinical at assessment, it is impossible to achieve clinical 
deterioration, (Barkham, Stiles, Connell & Mellor-Clark, 2011).  Therefore, the rate of 
‘harm’ is calculated as the number of patients demonstrating RCSC as a proportion of 
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those who were non-clinical at assessment.  Patients were classified as the following 
‘reliably improved’ (positive RCI), ‘clinically improved’ (shift from case to non-case), 
‘recovered’ (positive RCI and case to non-case), ‘reliably deteriorated’ (negative RCI), 
‘clinically deteriorated’ (shift from non-case to case) and ‘harmed’ (negative RCI and 
non-case to case).     
To consider the potential incremental increase of group alliance (GSRS scores), 
repeated Analysis of Variance (ANOVA) compared the means from each weekly 
session.  Repeated ANOVA was also used to analyse the weekly rated anxiety and 
depression data.  In addition, non-parametric tests (Mann-Whitney U) were used to 
investigate the potential relationship between recovery and reported group alliance.   
Finally, potential confounding variables were considered as follows.  Non-
parametric tests (Mann-Whitney U) were run to consider any differences in gender.  
Independent samples t-tests were used to investigate any differences based on whether 
patients completed all six sessions of the group.  A one-way ANOVA was used to 
consider any differences according to referral reason (anxiety, depression or mixed). 
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Results 
Power Analysis 
 A priori power analysis was carried out using G*Power-3 (Faul, Erdfelder, 
Lang, & Buchner (2007) to calculate the required sample size; Cohen (1977) suggested 
that 80% power is required to achieve significant findings when conducting a power 
analysis.  Based on previous research in this field (Haringsma et al., 2006), in order to 
show a similar effect size with an alpha or significance level of .05, and a power of 0.8 
based on linear multiple regression, the required sample size was 41.  The power 
analysis was repeated using paired samples t-test, as was used in analysis, alpha or 
significance level of .05, effect size of 0.4 and the actual sample size of 34 patients, 
which suggests the study has a power of 0.62.  In order to achieve power of 80% (0.8), a 
power analysis suggests that 52 patients were actually needed.  All statistical results 
should be considered in the context of this information.   
Attrition 
Of the 41 patients who consented to the research, 7 (17%) dropped out of the 
study during group treatment.  Reasons were physical illness (N=2), and not stated 
(N=5).  Independent samples t-tests (95% confidence interval) showed no significant 
differences in assessment scores for HADS anxiety (t (38) = -.360, p = .720), HADS 
depression (t (38) = .583, p = .563), CORE-OM (t (38) = -.338, p = .737) and HONOS 
65+ (t (37) = -1.185, p = .244) between completers and non-completers.       
Completer Analyses 
Table 1 displays the demographic details and assessment scores for completers 
and non-completers.  The sample was culturally homogenous in both groups (100% 
white British) and a high percentage (97%) were prescribed medication.  Figure 2 
shows a box plot of gender and age for completers, highlighting the median age in both 
genders of patients, and that there was a wider age range of female patients, although 
this is likely a reflection of the higher number of female patients (82%).  Patient ages 
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ranged from 65 years to 90 years, apart from one patient who was an outlier at 95 years 
old.  Normal distribution was considered using Z scores by dividing skewness from the 
standard error of skewness, and kurtosis from the standard error of kurtosis (Field, 
2009).  Using this method, assessment scores were normally distributed based on 
skewness; HADS anxiety (Z = -1.01), HADS depression (Z = 0.02), CORE-OM (Z = 
1.09), HoNOS 65+ (Z = 1.32), and kurtosis; HADS anxiety (Z = -0.77), HADS 
depression (Z = -0.21), CORE-OM (Z = 1.54) and HoNOS 65+ (Z = 0.03).  Normal 
distribution histograms can be seen in Appendix G.  
 
Table 1 
 
Demographic and Assessment Scores for Completers and Non-Completers 
 
 
    
Completers %,           
(N = 34)   
Non-Completers %,            
(N = 7) 
Mean age in years 
 
74.8 (SD=7.5) 
 
78.3 (SD=8.0) 
Gender 
    Male 
 
18 (6) 
 
14 (1) 
Female 
 
82 (28) 
 
86 (6) 
Ethnicity 
    White British 
 
100 (34) 
 
100 (7) 
Other 
 
0 
 
0 
Marital Status 
    Married 
 
50 (17) 
 
43 (3) 
Divorced 
 
15 (5) 
 
0 (0) 
Widowed 
 
32 (11) 
 
57 (4) 
Single 
 
3 (1) 
 
0 (0) 
Medication for 
anxiety/depression 
    Yes 
 
97 (33) 
 
86 (6) 
No 
 
3 (1) 
 
14 (1) 
Referral Reason 
    Anxiety 
 
18 (6) 
 
14 (1) 
Depression 
 
20 (7) 
 
14 (1) 
Mixed 
 
62 (21) 
 
72 (5) 
Assessment HADS A 
 
10.82 (SD=5.2) 
 
11.67 (SD=5.8) 
Assessment HADS D 
 
9.15 (SD=4.5) 
 
8 (SD=4.1) 
Assessment CORE-OM 
 
14.40 (SD=6) 
 
15.30 (SD=9) 
Assessment HoNOS 65+   9.13 (SD=4.7)   11.43 (SD=4.5) 
 
Note.  HADS A=Hospital Anxiety and Depression Scale anxiety subscale, HADS D=Hospital 
Anxiety and Depression Scale depression subscale, CORE-OM=Clinical Outcomes in Routine 
Evaluation-Outcome Measure, HoNOS 65+=Health of the Nation Outcome Scale 65+. 
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Figure 2. Box Plot to Show Age Distribution and Gender of Patients 
 
 
Effectiveness; Group Level Analysis 
Tables 2, 3 and 4 display the means and standard deviations for measures from 
assessment to termination, termination to follow-up and assessment to follow-up 
respectively.  Mean scores improved for all measures from assessment to termination.  
From termination to follow-up differences in scores continued to improve except for the 
HADS depression subscale which slightly deteriorated (difference indicated as a 
negative number).  Differences in scores between assessment and follow-up indicate 
continued improvement across all measures, most of which are larger than the 
differences measured at termination (apart from the HADS depression subscale which 
has a smaller improvement at follow-up).      
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Table 2 
Assessment versus Termination Data and Comparisons 
Measure                                
Assessment-
Termination N
a
  df 
Assessment 
Mean (SD) 
Termination 
Mean (SD) Difference t p d 
HADS-Anxiety 33 32 10.85 (5.30) 9.35 (4.61) 1.50 2.08 .045* 0.3 
HADS-Depression 33 32 9.10 (4.54) 7.24 (3.80) 1.86 2.01 .053 0.4 
CORE-OM 32 31 14.30 (6.00) 12.00 (7.10) 2.30 2.73 .01* 0.4 
HONOS 65+ 30 29 9.23 (4.81) 8.40 (4.60) 0.83 1.4 .171 0.2 
 
 
Table 3 
Termination versus Follow-Up Data and Comparisons 
Measure         
Termination-    
Follow Up N
a
  df 
Termination 
Mean (SD) 
Follow Up 
Mean (SD) Difference t p d 
HADS-Anxiety 33 32 9.35 (4.61) 9.06 (5.40) 0.29 0.37 .714 0.1 
HADS-Depression 33 32 7.24 (3.80) 7.26 (4.31) -0.02 -0.02 .981 -0.01 
CORE-OM 33 32 12.0 (7.0) 11.30 (7.67) 0.70 0.54 .592 0.1 
HONOS 65+ 31 30 8.19 (5.0) 7.74 (4.40) 0.45 0.69 .493 0.1 
 
 
Table 4 
Assessment versus Follow-Up Data and Comparisons 
Measure         
Assessment-Follow 
Up N
a
 df 
Assessment 
Mean (SD) 
Follow Up 
Mean (SD) Difference t p d 
HADS-Anxiety 34 33 10.82 (5.20) 8.94 (5.35) 1.88 2.03 .051 0.4 
HADS-Depression 34 33 9.15 (4.50) 7.43 (4.35) 1.72 1.71 .097 0.4 
CORE-OM 33 32 14.30 (6.0) 11.40 (7.6) 2.90 3.45 .002** 0.5 
HONOS 65+ 31 30 9.23 (4.73) 7.65 (4.40) 1.58 2.53 .017* 0.3 
 
                                                             
a
 N differs dependent on completion of measures at both time points 
*p <.05, two-tailed test 
**p < .01, two-tailed test 
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Statistically Significant Changes 
Table 2 also displays the assessment to termination paired samples t-tests (95% 
confidence interval) and the uncontrolled effect sizes. Both HADS anxiety subscale (t 
(32) = 2.086, p = .045) and CORE-OM (t (31) = 2.732, p = .010) significantly reduced 
over time, with the HADS depression subscale close to significance (t (32) = 2.013, p = 
.053).  There was a ‘small’ effect size for the HONOS 65+ and ‘small to medium’ effect 
size for both HADS subscales and the CORE-OM (Cohen, 1988).   
There were no significant differences for HADS anxiety (t (32) = 0.37, p = 
.714), HADS depression (t (32) = -0.02, p = .981), CORE-OM (t (32) = 0.54, p = .592) 
or HONOS 65+ (t (30 = 0.69, p = .493) and effect sizes were ‘small’ for all measures on 
the termination to follow-up comparisons.  
Table 4 displays the assessment to follow-up paired samples t-tests and 
uncontrolled effect sizes.  There were significant differences on the CORE-OM (t (32) = 
3.45, p = .002) and HoNOS 65+ (t (30) = 2.53, p = .017).  The HADS depression (t (33) 
= 1.71, p = .97) and HADS anxiety subscale (t (33) = 2.03, p = .051) were non-
significant.  Effect sizes were ‘small to medium’ for all measures; all effect sizes were 
larger assessment to follow-up than assessment to termination.   
Effectiveness; Benchmarking Data 
Table 5 compares current effect sizes with the extant older adult evidence base 
for group interventions where it was possible to calculate effect sizes.  The current 
anxiety effect size appears comparable with previous anxiety group research, whilst the 
current depression effect size is much lower than previous depression group research.  
Current effect sizes are similar to the one other mixed anxiety and depression 
intervention research.    
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Table 5 
Comparison of Effect Sizes using Extant Research 
 
      Intervention   
Study N                  Depression Anxiety Mixed 
  
Mean = 1.1 Mean = 0.6 
 Arean et al., (1993)
1
 39 1.53 
  Arean et al., (2005)
3
 67 0.27 
  Beutler et al., (1987)
1
 56 0.74 
  Cappeliez (2000)
1
 21 1.8 
  Haringsma et al., (2006)
4
 119 0.6 
  Hautzinger & Welz (2004)
2
 55 0.9 
  Klausner et al., (1998)
1
 24 0.75 
  Konnert et al., (2009)
2
 64 1.17 
  Kunik et al., (2008)
1
 123 0.74 
  Rokke et al., (2000)
1
 34 1.92 
  Steur et al., (1984)
1
 20 1.3 
  Radley et al., (1997)
5
 6 
 
0.33 
 Stanley et al., (1996)
7
 48 
 
0.62 
 Stanley et al., (2003)
7
 85 
 
1 
 Wetherell et al., (2003)
6
 75 
 
0.35 
 Schimmel-Spreeuw et al., 
(2000)
2 8 51 
  
0.5-depression  
0.34-anxiety 
Current Study
4
 34     
0.3-depression    
0.4-anxiety 
 
Measures used to calculate effect sizes:
  
1
 Beck Depression Inventory-II 
2
 Geriatric Depression Scale 
3
 Hamilton Depression Rating Scale 
4
 Hospital Anxiety and Depression Scale 
5
 Hospital Anxiety and Depression Scale (Anxiety Subscale) 
6
 Beck Anxiety Inventory 
7
 State Trait Anxiety Inventory  
8
 Symptom Checklist-90 
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Effectiveness; Individual Level Analysis 
 
Category outcome rates were calculated for assessment to termination and 
assessment to follow-up.  Table 6 displays the rates for positive and negative clinical 
change, positive and negative reliable change, recovery and harm.  When comparing 
assessment to termination, 15 patients were classified as either reliably improved or 
recovered on the CORE-OM, 9 patients on the HADS anxiety, and 12 patients on the 
HADS depression.  Using the same comparison, the single patient reliably deteriorated 
and no patients were harmed on the CORE-OM, five patients reliably deteriorated or 
were classified as harmed on the HADS anxiety measure and two patients reliably 
deteriorated with the single patient classified as harmed on the HADS depression 
measure.   
Between assessment and follow-up, rates of reliable improvement and recovery 
increased on all measures; 20 patients on the CORE-OM, 15 patients on the HADS 
anxiety measure and 14 patients on the HADS depression measure respectively.  Using 
the same comparison, rates of reliable deterioration and harm were least found on the 
CORE-OM with the single person reliably deteriorating and no patients classified as 
harmed.  Both the HADS anxiety and depression measures indicated six patients 
reliably deteriorated or were classified as harmed.   
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Table 6  
 
Reliably and Clinically Significant Change at Termination and Follow-Up 
 
  N 
Clinical at 
Assessment     
N (%)  
Reliably 
Improved    
N (%) 
Clinically 
Improved    
N (%) 
Recovered   
N (%)   
Non Clinical at 
Assessment   
N (%)  
Reliably 
Deteriorated   
N (%)  
Clinically 
Deteriorated   
N (%) 
Harmed   
N (%) 
Termination Anxiety 
(HADS-A) 33 24 (73) 7 (21) 2 (8) 2 (8) 
 
9 (27) 3 (9) 3 (33) 2 (22) 
Termination 
Depression          
(HADS-D) 33 18 (55) 7 (21) 6 (33) 5 (28) 
 
15 (45) 2 (6) 3 (20) 1 (7) 
Termination          
Well-Being                
(CORE-OM) 32 27 (84) 9 (28) 7 (26) 6 (22) 
 
5 (16) 1 (3) 0 0 
Follow Up Anxiety        
(HADS-A) 34 25 (74) 8 (23) 9 (36) 7 (28) 
 
9 (26) 3 (9) 3 (33) 3 (33) 
Follow Up Depression 
(HADS-D) 34 19 (56) 8 (23) 9 (47) 6  (31) 
 
15 (44) 4 (12) 4 (27) 2 (13) 
Follow Up Well-Being 
(CORE-OM) 33 28 (85) 11 (33) 12 (43) 9 (32)   5 (15) 1 (3) 2 (40) 0 
GROUP CBT FOR ANXIETY AND DEPRESSION IN OLDER ADULTS 25 
 
 
Session Analysis; Therapy Alliance, Anxiety and Depression 
 
Table 7 displays the ANOVA results for the total GSRS scores and weekly 
anxiety and depression.  Mean scores for the total GSRS suggest weakest group alliance 
for sessions 3 and 4 of the intervention, however the larger standard deviations suggest 
that there may have been more variability in these scores than is reflected in the means.  
GSRS mean score was highest at week 6 suggesting therapy alliance was at its strongest 
at the end of the group.  Mauchly’s Test of Sphericity indicated that the assumption of 
sphericity had been violated (X² (14) = 86.572, p <.001), therefore degrees of freedom 
were corrected using Greenhouse-Geisser estimates of sphericity (έ = 0.462).  Results 
show that there was no significant effect of sessions on therapy alliance as measured by 
the GSRS (F (2.312, 41.621) = 2.856, p = .062).   
Table 7 also displays that anxiety was reported as most improved by session 5 
and as worst at session 1.  Mauchly’s Test of Sphericity indicated that the assumption of 
sphericity had not been violated (X² (14) = 21.793, p =.086). Results show that there 
was a significant effect of sessions on reported anxiety (F (5, 90) = 2.598, p = .030).  
Post hoc analyses using the Bonferroni correction revealed that there was no significant 
effect of anxiety when considering pair-wise comparisons of session 1 with all 
subsequent sessions (all p’s > .05).  Depression was rated as most improved in session 6 
and worst in week 1.  Mauchly’s Test of Sphericity indicated that the assumption of 
sphericity had been violated (X² (14) = 24.068, p = .047), therefore degrees of freedom 
were corrected using Greenhouse-Geisser estimates of sphericity (έ = 0.691).  Results 
show that there was no significant effect of sessions on reported depression (F (3.454, 
62.166) = 1.841, p = .141).   
No significant results were found for between therapy alliance (GSRS scores) 
and patients who recovered (RCSC) versus those who did not at assessment to 
termination, HADS anxiety (U = 15.00, z = -1.257, p = .209), HADS depression (U = 
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65.50, z = -.344, p = .731), CORE-OM (U = 69.00, z = -.685, p = .494) or assessment to 
follow up, HADS anxiety (U = 73.50, z = -.904, p = .366), HADS depression (U = 
71.50, z = -.571, p = .568), CORE-OM (U = 108.00, z = -.178, p = .859). 
 
Table 7 
Means, Standard Deviations and ANOVA scores from the Group Session Rating Scale and 
Additional Anxiety and Depression Scales 
N = 19# 
Session 
1 Mean 
(SD) 
Session 
2 Mean 
(SD) 
Session 
3 Mean 
(SD) 
Session 
4 Mean 
(SD) 
Session 
5 Mean 
(SD) 
Session 
6 Mean 
(SD) 
            
F-Value 
GSRS Total 
36.20 
(2.4) 
36.32 
(3.14) 
32.74 
(7.50) 
34.16 
(7.86) 
35.84 
(3.80) 
37.11 
(2.50) 
2.856 
(p=.062) 
        
Anxiety 
5.42 
(3.90) 
6.42 
(3.60) 
5.89 
(3.20) 
5.74 
(3.60) 
7.84 
(2.34) 
7.32 
(3.33) 
2.598 
(p=.030) 
        
Depression 
5.37 
(3.63) 
5.74 
(3.70) 
6.32 
(3.61) 
6.00 
(3.40) 
7.16 
(3.13) 
7.47 
(3.10) 
1.841 
(p=.141) 
 
 
*p<0.05, two tailed test 
#N is lower as patients needed to complete all six sessions to be include in analysis 
 
 
Potential Confounding Variables  
 No significant differences were found with regards to gender for any of the 
outcome measures at assessment HADS anxiety (U = 76.00, z = -.362, p = .717), HADS 
depression (U = 56.00, z = -1.275, p = .202), and CORE-OM (U = 66.00, z = -.700, p = 
.484), termination HADS anxiety (U = 76.50, z = -.211, p = .833), HADS depression (U 
= 80.50, z = -.023, p = .981), and CORE-OM (U = 78.50, z = -.117, p = .907) or follow-
up HADS anxiety (U = 83.00, z = -.045, p = .964), HADS depression (U = 67.50, z = -
.749, p = .454) and CORE-OM (U = 71.50, z = -.565, p = .572).  
Any differences between patients who attended all six sessions of the group and 
patients who had missed any session were investigated.  Results showed no significant 
differences at assessment for HADS anxiety (t (32) = -0.615, p = .543), HADS 
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depression (t (32) = 0.441, p = .662), or CORE-OM (t (17.71) = -0.096, p = .925). No 
significant differences were found for termination HADS anxiety (t (31) = -0.316, p = 
.754), HADS depression (t (31) = -0.238, p = .813), or CORE-OM (t (31) = 0.095, p = 
.925).  No significant differences were found for follow-up HADS anxiety (t (32) = 
0.502, p = .619), HADS depression (t (32) = 0.203 p = .840), or CORE-OM (t (20.32) = 
0.175, p = .863).   
Table 8 contains the one-way ANOVA results for any differences dependent on 
whether patients were referred for anxiety, depression or mixed anxiety and depression.  
Results were not significant at assessment for the HADS depression (F (2, 31) = 1.547, 
p = .229, however, were significant for HADS anxiety (F (2, 31) = 3.499, p = .043) and 
CORE-OM (F (2, 30) = 4.941, p = .014).  There continued to be a significant difference 
for termination HADS anxiety (F (1, 9) = 17.908, p < .001) and CORE-OM (F (1, 28) = 
23.186, p <.001) after controlling for the effect of assessment HADS anxiety and 
CORE-OM using analysis of co-variance (ANCOVA).  Termination HADS depression 
was also significant (F (2, 30) = 3.508, p = .043) and continued to be significant at 
follow-up (F (2, 31) = 4.286, p = .023).  There also continued to be a significant 
difference at follow-up for HADS anxiety (F (1, 30) = 6.856, p = .014) and CORE-OM 
(F (1, 29) = 29.816, p <.001) after controlling for the effect of assessment HADS 
anxiety and CORE-OM.     
Post hoc analyses (Bonferroni) revealed all significant differences were between 
patients referred with depression and those referred with mixed anxiety and depression.  
Differences were evident at assessment on HADS anxiety (p = .046), and CORE-OM (p 
= .011), and also termination HADS depression (p = .039) and follow-up HADS 
depression (p = .041).   All significant results suggested that patients referred with 
mixed anxiety and depression had greater levels of distress.    
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Table 8 
 
Comparison of Assessment, Termination and Follow-up Measures Based on Reasons for Referral 
 
 
Assessment Means (SD) 
 
Termination Means (SD) 
 
Follow-Up Means (SD) 
  HADS A  HADS D CORE-OM   HADS A  HADS D  CORE-OM   HADS A  HADS D CORE-OM 
Anxiety 9.67 (4.88) 7.67 (3.32) 14.5 (6.15) 
 
9.83 (4.30) 7.50 (3.10) 9.5 (4.91) 
 
6.83 (5.34) 5.50 (3.02) 9.70 (7.39) 
Depression 7.00 (6.90) 7.29 (6.04) 8.90 (4.74) 
 
6.43 (4.35) 4.14 (3.93) 7.5 (6.10) 
 
7.43 (5.88) 4.43 (3.50) 5.90 (5.32) 
Mixed 12.43 (4.02) 10.19 (4.06) 16.20 (5.34) 
 
10.23 (4.60) 8.25 (3.52) 14.00 (7.10) 
 
10.05 (5.14) 8.98 (4.31) 13.50 (7.52) 
F-Value                
(p value) 
3.499 
(p=.043)* 
1.547 
(p=.229) 
4.941 
(p=.014)*   
17.908  
(p<.001)** 
3.508 
(p=.043)* 
23.186   
(p<.001**)   
6.856   
(p=.014)* 
4.286 
(p=.023)* 
29.816       
(p<.001)** 
 
 
*p < 0.05, two tailed test 
**p < 0.01, two tailed test 
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Discussion 
This study adds to the sparse evidence considering anxiety and depression group 
CBT with older adults.  The main aim of the research was to investigate whether a 
manualised CBT group intervention for anxiety and depression was effective with older 
adults.  As this was a feasibility study, the research was also an opportunity to explore 
the practicalities of conducting such research, and identify avenues for further 
investigation.  Previous practice based evidence considering CBT groups for depression 
and CBT groups for anxiety with this age group have indicated promising findings 
(Beutler et al., 1987), Cappeliez, (2000), Nance (2012), Radley et al., (1997), 
Schimmel-Spreeuw et al., (2000) and Steur et al., (1984).  The present study compared 
anxiety, depression and psychological well-being at assessment, termination, and six 
week follow-up from a group CBT intervention.  Staff observations of patient health 
were also monitored.  In addition, group therapy alliance and weekly rated anxiety and 
depression was considered across all six sessions of the intervention. 
Summary of Findings 
The findings suggest that attendance at a group CBT intervention appears to 
lower anxiety, depression and improve psychological well-being for older adults.  All 
measures demonstrated improvement immediately after the intervention and at six week 
follow-up, in comparison to initial assessment.  Mean scores significantly improved 
between assessment and termination for anxiety and psychological well-being.  
Psychological well-being also significantly improved between assessment and follow-
up.  The termination to follow-up comparisons indicated stasis in patient outcomes 
suggesting that patients were not losing the gains made in the group, nor making further 
gains without the support of the group.   
Effect sizes were ‘small to medium’ for all outcome measures from assessment 
to termination and follow-up.  The smallest effect sizes were for staff rated patient well-
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being and the largest effect sizes were found for the self reported psychological well-
being.  Benchmarking of effect sizes with the existing CBT group intervention literature 
indicates depression effects were larger in previous studies.  In terms of anxiety, effect 
sizes were consistent with previous research.  The current anxiety and depression effect 
size is very similar to the Schimmel-Spreeuw et al., (2000) study using a similar method 
with a similar patient group.  The existing evidence base for depression CBT groups is 
more extensive than anxiety and has a number of RCTs (Abraham et al., 1992; Arean et 
al., 1993; Arean et al., 2005; Haringsma et al., 2006; Hautzinger & Welz, 2004; 
Klausner et al., 1998; Konnert et al., 2009; Kunik et al., 2008; Rokke et al., 2000; 
Wilkinson et al., 2009) which may have yielded higher effect sizes when compared to 
practice based evidence.   
Statistical significance has limited bearing on how clinically meaningful results 
can be (Jacobson & Truax, 1991).  This highlights the importance of an effective 
clinical intervention needing to produce both clinical and reliable significant change.  
Recovery rates were evident on all measures at termination and follow-up.  Rates of 
recovery were highest for psychological well-being as measured by the CORE-OM.  
However, there was evidence that harm did also occur.  Evidence suggests that it is 
imperative to consider rates of harm in psychological therapy (Lilienfeld, 2007) and that 
a relatively small minority can deteriorate following psychological intervention with 
estimates ranging from three to 10% (Mohr, 1995; Strupp, Hadley, & Gomez-Schwartz, 
1977).  Current rates of harm from the group were greater than this, varying from 7% 
(N=1) to 33% (N=3).  It should be noted that these proportions may seem inflated as 
calculations only included patients who were non-clinical at assessment.  Rates of 
reliable deterioration (including all patients) were lower, varying from 3% (N=1) to 
12% (N= 4) which is comparable with suggested estimates (Mohr, 1995; Strupp et al., 
1977).  Minimal information was collected about other confounding variables that could 
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have impacted self reported mental health, therefore rates of recovery and harm could 
be unrelated to the group intervention.   
The measure of therapy alliance suggested that the final session of the 
intervention was rated more positively than the previous sessions, although these results 
were not significant.  The lack of significant results were surprising, particularly as the 
latter half of the intervention was more focussed on change methods, which could be 
hypothesised to seem more relevant to the goals and topics of patients.  There were no 
significant differences for individuals who made RCSC and their rating of therapy 
alliance.  Patients reported significant improvements to weekly rated anxiety and 
improvements to depression, however these were not significant. 
Rate of attrition is consistent with other older adult group CBT research (Stanley 
et al., 1996; Stanley et al., 2003).  Attrition rates in studies of older adults have been 
found to be higher than younger patients (Gould, Otto, Pollack, & Yap, 1997), this 
could be due to practical difficulties (e.g. physical illness, lack of transport) reported by 
older adults as reasons for dropping out of therapy (Wetherell, Gatz & Craske, 2003).   
Findings suggested that gender or full attendance at all therapy sessions did not 
have a significant impact on outcome measures.  As previous research considering 
mixed anxiety and depression used a female only sample (Schimmel-Spreeuw et al., 
2000), current findings suggest this is a suitable intervention for both genders.  Results 
suggested that patients referred with mixed anxiety and depression were significantly 
more anxious, depressed and reported greater psychological distress at assessment, 
termination and follow up.  This supports the notion that individuals with mixed anxiety 
and depression tend to have greater severity of both disorders, (Schoevers et al., 2003).  
This encourages the targeted use and evaluation of clinical intervention with this patient 
group, particularly as there are no known group manualised interventions with older 
adults addressing both anxiety and depression effectively.   
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The mean age of the current research (74.8 years) was generally higher than that 
of existing literature for group CBT with older adults.  Only two studies report a higher 
mean age for group depression interventions of 81.10 years (Konnert et al., 2009; 
Abraham et al., 1992), and one study for group anxiety of 85 years (Stanley et al., 
2003).  This research is also the first to consider clinical effectiveness of mixed anxiety 
and depression group CBT with both genders.    
Methodological Critique 
 There are numerous compromises when collecting data in routine clinical 
practice (Barkham & Margison, 2007) and therefore results from this research should be 
interpreted within this context.  An obvious limitation is the lack of control comparison 
group (Corney & Simpson, 2005; Lilienfeld, 2007).  This limits the certainty with 
which improvement can be attributed to the group intervention.  As all patients were 
already in receipt of mental health services, varying degrees of ongoing input from the 
service occurred before and during the group.  Patients were asked about any other 
mood management (e.g. one to one therapy sessions) or any significant life events (e.g. 
bereavement) at each time point.  This data was not consistently collected, and varied 
dependent on subjective ratings of other ongoing mental health interventions (such as 
some patients gave information about community psychiatric nurse visits or luncheon 
clubs), or subjective ratings of significant life events (such as ongoing family or health 
problems).  It was not possible to ascertain duration of other ongoing mental health 
interventions if the data was not collected by the Chief Investigator; therefore it was 
omitted from any analysis.  Systematic recording of concurrent interventions and 
duration of anxiety and depression would have helped ascertain the relationship 
between improvement in anxiety and depression and the intervention more clearly.  The 
length of follow-up (six weeks) was also very short and may not have been an 
indication of longer term effects of the group.     
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Due to a service reconfiguration during the data collection period, it was only 
possible to recruit 34 patients.  The first six groups were run from a day hospital, but as 
a result of service reconfiguration the day hospital was shut.  This impacted the number 
of referrals and practicalities of attending the group, as transport to the group was no 
longer available.  The last two groups were therefore delivered in the community.  
Unavailable transport can substantially impact how realistic attendance is for older adult 
patients (Agronin, 2009).  Although the sample size was smaller than was anticipated, 
in comparison to extant evidence the numbers were not dissimilar.   
Outcome measures such as the HADS and HoNOS 65+ were chosen based on 
the practicality of use within the service, rather than whether they were the most 
psychometrically sound for this client group.  The HoNOS 65+ tended to be completed 
by different members of staff at all time points, which brings into question the reliability 
of the data and may explain the relatively small effect sizes.  Older adult specific 
measures of anxiety and depression e.g. Geriatric Anxiety Inventory (Pachana, Byrne, 
Siddle, Koloski, Harley & Arnold, 2007) and Geriatric Depression Scale (Yesavage et 
al., 1983) may have been better suited to capture the specific needs of this client group.       
From the available data, it is not possible to ascertain which aspects of the group 
created any change, e.g.  psychoeducation or ‘being understood by, and understanding 
others’ through the group format (van der Ven, 2003).  Also, the lack of 
competency/model fidelity measure limits how much is known about the intervention 
delivery.  Although facilitators received group supervision with the NHS Supervisor of 
the research, and completed observer checklists in every session, there was natural 
variability in the delivery of the Anxiety and Depression Management Manual in terms 
of how rigidly session content was maintained or possible other variables e.g. the 
clinical experience of facilitators.   
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 All findings must be considered in the context of the sample size being 
statistically underpowered.  This is particularly pertinent for the repeated measures 
ANOVA results as the sample number was as low as 19 when considering the session 
analysis of therapy alliance, anxiety and depression.   
Clinical Implications  
Overall, this study suggests that the Anxiety and Depression Management Group 
is a promising clinical intervention.  This is an innovative piece of research, from which 
the clinical implications of the intervention demonstrate potential.  As mixed anxiety 
and depression is a core part of standard clinical work with older adults, an effective 
group manualised intervention is valuable.  The increasing demands on the modern 
NHS mean that effectively engaging service users via a group intervention is potentially 
both time and cost effective (Simpson, Carlson & Trew, 2001; van der Ven, 2003).  
This is particularly pertinent when delivering a low-intensity, short psychoeducational 
intervention to secondary care mental health service users (NICE guideline 113, 2011).  
The Anxiety and Depression Management Group is the shortest reported intervention 
from the literature in this field and also addresses both anxiety and depression, 
heightening its clinical potential.  
The manualised intervention offered skill development for staff members and 
confidence with regard to CBT knowledge, potentially increasing psychological 
awareness amongst mental health professionals and promoting a client centred 
approach.   
Future Research 
Due to the limited literature investigating CBT groups with older adults, this 
research provides impetus and avenues for future research.  The current study has 
highlighted the feasibility of conducting further research to develop these preliminary 
findings.  The practicality of delivering group CBT with OAs has raised issues about the 
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importance of transport and venue to support patient attendance and ultimately obtain a 
larger sample size.  It is important to evaluate the Anxiety and Depression Management 
Manual using both passive (i.e. TAU) and active (i.e. other psychotherapies) control 
comparisons.  Extant research suggests that the effectiveness of group CBT is less clear 
when compared to other active conditions (Stanley et al., 1996; Steur et al., 1984; 
Wetherell et al., 2003; Wilkinson et al., 2009). 
Investigations of how group psychological intervention creates both recovery and harm 
are indicated.  Also, longer term follow-up of the group would access durability of 
clinical change far more effectively. 
The Anxiety and Depression Management Manual encourages between session 
work.  Previous research has suggested that better outcomes are associated with greater 
adherence to homework (Wetherell et al., 2005).  Adherence to homework was not 
formally recorded; however this could be considered in future research.  Other 
information that was not recorded but could be further explored was the onset and 
duration of mixed anxiety and depression, and systematic consideration of model 
fidelity/competency to check that the intervention is consistently being delivered. 
 Clearly, there is a need for more research considering concurrent depression and 
anxiety management for older adults.  Potentially valuable information was missed 
through using solely quantitative methods.  As data was collected (particularly at the 
follow-up stage), patients gave examples of what they found helpful about the group, 
and which strategies they were continuing to implement.  This may have also provided 
further insight into those patients classified as recovered or harmed.  Therefore, further 
research could incorporate a qualitative element to data collection.   
  Finally, the manualised intervention has received positive feedback from 
different clinical disciplines that have facilitated the groups.  There is potential for 
research to consider how manualised psychological interventions, such as this one, 
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influence the clinical practice and confidence of using a psychological model (in this 
case CBT for anxiety and depression) for non psychological professionals.       
Conclusions 
 The current research considered the clinical effectiveness of a six week group 
CBT intervention with older adults with mixed anxiety/depression.  The intervention 
indicates promising findings with anxiety, depression, psychological well-being and 
staff observation ratings of patient well-being, all improving following the group 
intervention.  The research highlights the potential clinical advantages of manualised 
group CBT with older adults.  Future more controlled evaluations are indicated to meet 
the evident needs of this patient group and provide a more credible evaluation of 
change.       
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APPENDIX A 
 
 
 
 
Author, year  Outcome 
Measure  
 Is the 
hypothesis/aim/objective 
of the study 
clearly described? 
  
 Are the 
characteristics 
of the patients 
included in the 
study clearly 
described?   
 Are the 
main findings 
of the study 
clearly 
described?  
 Have actual 
probability values 
been 
reported(e.g. 
0.035 rather than 
<0.05) for the 
main outcomes 
except where the 
probability value 
is less than 
0.001?  
 Were the 
subjects 
asked to 
participate in 
the study 
representative 
of the entire 
population 
from which 
they were 
recruited?  
 Were those 
subjects who 
were prepared 
to participate 
representative 
of the entire 
population from 
which they 
were recruited?  
 Were the 
statistical 
tests used to 
assess the 
main 
outcomes 
appropriate?  
Lowe & Reynolds (2006) AMAS - E 1 1 1 0 0 0 1 
Segal et al (2010) GAS 1 1 1 0 0 0 1 
Yochim et al (2011) GAS 1 1 1 0 0 0 1 
Pachana et al (2006) GAI 1 1 1 1 0 0 1 
Byrne et al (2010) GAI 1 1 1 0 0 0 1 
Cheung (2007) GAI 1 1 0 0 0 0 1 
Matheson et al (2012) GAI 1 1 1 0 0 0 1 
Cheung et al (2012) GAI 1 1 1 1 0 0 1 
Byrne & Pachana (2011) GAI - SF 1 1 1 1 0 0 1 
Diefenbach et al (2009) GWS 1 1 1 1 0 0 1 
Hopko et al (2000) WS 1 1 1 1 0 0 1 
Wisocki et al (1986) WS 1 1 0 1 0 0 1 
Hunt et al (2003) WSOA-R 0 1 1 1 0 0 1 
Stanley, Beck & Zebb (1996) WS 1 1 1 1 0 0 1 
Stanley et al (2001) WS 1 0 1 1 0 0 1 
Lowe & Reynolds (2000) AMAS - E 1 1 1 1 0 0 1 
Sinoff et al (1999) SAST 1 1 1 0 0 0 1 
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Appendix C1 
 
 
 
 
The effectiveness of group psychoeducational CBT for mixed 
anxiety and depression in older adults: A feasibility study 
 
Information Sheet 
 
Anxiety and depression are common mental health difficulties.  It would be very 
useful to understand what helps with managing these difficulties.  We would like 
to know whether the anxiety and depression management group we run is 
helpful.  This will mean services can adapt in the future and improve what is 
offered to be what is needed.  Please take time to read the following information 
carefully and discuss it with others if you wish. Ask us if there is anything that is 
not clear or if you would like more information. Take time to decide whether or 
not you wish to take part. Thank you for reading this. 
 
“Why do this study?” 
The study aims to find out what type of help is useful for people over the age of 
65 to manage their anxiety and depression.  This will help us ensure the service 
we provide is appropriate for you and others.  This is a ‘feasibility study’ which 
means it is an initial study to look at what is helpful before any future research in 
this area is planned.  
 
“Why have I been chosen?” 
You have been identified as someone who may benefit from attending the 
anxiety and depression management group.  The study aims to have 41 
participants in total in order to get enough information about the group. 
 
“What is the anxiety and depression management group?” 
The group is for two hours per week for six weeks and is an opportunity to meet 
other people who may be dealing with similar difficulties.  The group is led by  
members of staff who work in the NHS Trust, and is a way of looking at ways to 
manage depression and anxiety. 
 
“Does this affect my other care, for example my medication or other 
appointments?” 
No.  Everything continues as usual. 
 
“Do I have to take part?” 
Taking part is completely voluntary.  Your healthcare will not be affected in any 
way if you decide to not take part. 
If you do decide to take part you will be given this information sheet to keep (and 
be asked to sign a consent form).   
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Appendix C1 
“What if I change my mind?” 
You can withdraw at any time from the research without it affecting any of your 
care.  You do not have to give a reason.  If you decide to stop attending the 
group sessions, this would also be your choice and would not affect the rest of 
your healthcare in any way. 
 
“What does taking part in the study involve?” 
Completing some questionnaires about your mental health difficulties.  These 
should take about half an hour, and you will be asked to complete these three 
times (once before attending the group, once immediately after and a final time 
six weeks after the group has ended).  The anxiety and depression 
management group runs for six weeks and you will be given details of the dates 
of which group you can attend. 
 
“What are the benefits of taking part?” 
You can attend the anxiety and depression management group regardless of 
whether you decide to take part in this research.  If you do take part, it will help 
give us information about how our services can be improved. 
 
“What are the possible risks of taking part?” 
The anxiety and depression management group asks you to think about the 
different ways anxiety and depression affects your life, this may sometimes be 
upsetting.  You will not be asked to do anything that you do not consent to and 
the members of staff that facilitate the group will be there to support you.  It will 
take about half an hour per time to fill out the questionnaires.  This can be 
arranged for a time that is suitable for you and if at any time you feel you do not 
wish to continue taking part in the research you can withdraw without giving a 
reason. 
 
“Will the information collected in the study be confidential?” 
Yes, all information will be kept confidential.  Your name or personal information 
will not be mentioned in any reports of the study.  If you would like to be 
informed of the results of the study please mention this to your clinician.  One of 
the researchers may contact you to arrange to help you fill in the questionnaires 
if this is needed, however all information will be confidential. 
 
“What if I have further questions?” 
Please call 0114 2226650 and leave a message for Manreesh Bains (Trainee 
Clinical Psychologist) who will call you back as soon as possible. 
 
“What if something goes wrong?” 
Please contact the chief investigator, Manreesh Bains on 0114 2226650 and 
leave a message to be contacted back.  This study is being sponsored and 
indemnified by the University of Sheffield.  If you feel your concerns are not 
being dealt with, you can contact the University Secretary on 0114 2226649. 
Thank you for taking the time to read this information. 
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The effectiveness of group psychoeducational CBT for 
mixed anxiety and depression in older adults: A feasibility study 
 
Name of Researcher: Manreesh Bains 
 
Participant Identification Number for this project:                     
                                                                                                                  Please tick box 
1. I confirm that I have read and understand the information sheet dated 27 th 
May 2011 explaining the above research project and I have had the 
opportunity to ask questions about the project. 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving any reason and without there being any negative 
consequences. In addition, should I not wish to answer any particular 
question or questions, I am free to decline. 
 
3. I understand that my responses will be kept strictly confidential. 
I give permission for members of the research team to have access to my 
anonymised responses. I understand that my name will not be linked with 
the research materials, and I will not be identified or identifiable in the 
report or reports that result from the research.   
 
4.     I agree for the data collected from me to be used in future research  
 
5. I agree to take part in the above research project. 
 
 
________________________ ________________         _______________ 
Name of Participant Date Signature 
 
 
 
 
_________________________ ________________         _______________ 
Name of person taking consent Date Signature 
To be signed and dated in presence of the participant 
 
 
 
Manreesh Bains                         ________________         ___________________ 
Lead Researcher Date                                   Signature 
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The Anxiety and Depression Management Manual removed to ensure conformance with 
copyright legislation.  
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Observation checklists removed to ensure conformance with copyright legislation.  
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Appendix E2 
 
Adverse Incident/Complaint Form (Psychology Version) 
 
 
for health care research projects that the University of Sheffield 
is the research governance sponsor of 
 
This report form is for use if and when an adverse event incident occurs or a complaint is made 
relating to a health care research project where the University is the research governance sponsor. 
It should be completed by the Principal (or Chief) Investigator of the project and agreed with the 
Chair of the Ethics Committee or if a Clinical Unit project with the Director of Research Training.  It 
will then be discussed with the Head of Department.  
Guidance notes are included at the end of the report form (boxes on the form can be expanded). 
 
1. Research Project Title: The effectiveness of group psychoeducational CBT for 
mixed anxiety and depression in older adults: A 
feasibility study 
2. 6 digit URMS number (if applicable): 131005 
3. Principal/Chief Investigator: Manreesh Bains 
4. Supervisor/s: Stephen Kellett & Shonagh Scott 
5. Who initially discovered the adverse 
event/Complaint? 
 
6. When was the adverse event/complaint 
reported to the Principal/Chief Investigator? 
 
7. When was the adverse event/complaint 
reported to the Head of Department/School? 
 
8. When did the adverse event/complaint 
actually occur? 
 
9. Where did it happen? 
 
 
 
10. What actually happened and what was the impact of the adverse event/complaint? 
 
 
 
 
 
11. Why did the adverse event/complaint occur? 
 
 
 
 
 
 
12. Describe what action(s) have been taken to address the impact of this specific adverse 
event/complaint: 
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13. Describe what action(s) have been taken or are planned to limit the risk of a similar 
event/complaint re-occurring (add any general notes here to qualify the information given 
elsewhere in the report): 
 
 
 
 
Agreed and authorised by: 
Name of Principal/Chief Investigator: 
Manreesh Bains 
 
Signature: 
Date: insert date here 
Name of Head of Chair of Ethics Committee/Director of 
Research Training: 
Insert name here 
 
Signature: 
Date: insert date here 
 
Guidance Notes: 
1. 
Adverse events/complaints should be reported to the Head of Department/School as soon as possible and 
normally within 5 working days. If the time exceeds this, this should be a consideration in 13. 
 
2.  
Once complete, this report should be kept in the project’s site file for reference and a copy sent to Research 
and Innovation Services, New Spring House, 231 Glossop Road marked for the attention of the Head of the 
Planning and Business Support Section (Mrs Deborah McClean). 
 
3. 
Advice and guidance on completion of the report, analysis of the event and potential actions can be obtained 
from Research and Innovation Services (Lauren Smaller: ext. 21400). 
 
4. 
An ‘adverse event’ is an unexpected event that includes, but is broader than, unintended errors and mistakes 
which arise as a result of research activity and result in one or more research participants having symptoms 
or being caused physical or psychological harm or serious distress.  
 
Examples of this include: 
 
- A human participant has an adverse reaction to a drug treatment, the use of which had been 
approved by a Research Ethics Committee. 
-  
- An invasive instrument is used incorrectly, the use of which had been approved by a Research 
Ethics Committee, and the human participant suffers harm or has an extended stay in hospital. 
- A human participant is asked a series of questions regarding his/her sex life, a line of questioning 
that a Research Ethics Committee approved. However, for the interviewee, the questions revive 
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painful memories of being abused as a child and the interviewee suffers serious distress such as to 
warrant therapy. 
5.  
A ‘complaint’ is any approach made by a research participant to the researcher, their supervisor or 
collaborator with respect to the conduct of the study 
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Statistics 
 
T1_HONOS 
T1_CORE_TOT
AL T1_HADS_A T1_HADS_D 
N Valid 32 33 34 34 
Missing 2 1 0 0 
Mean 9.13 1.4394 10.82 9.15 
Median 9.00 1.3800 12.00 8.50 
Std. Deviation 4.689 .59636 5.202 4.487 
Variance 21.984 .356 27.059 20.129 
Skewness .547 .446 -.411 .011 
Std. Error of Skewness .414 .409 .403 .403 
Kurtosis .029 1.232 -.604 -.165 
Std. Error of Kurtosis .809 .798 .788 .788 
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